US5187193A
(en)
*
|
1988-09-12 |
1993-02-16 |
University Of Rochester |
Method for stimulating transplanted bone marrow cells
|
WO1991005571A1
(fr)
*
|
1989-10-10 |
1991-05-02 |
University Of Rochester |
Procede de fabrication des facteurs de croissance des cellules de la moelle osseuse
|
CA2113990A1
(fr)
*
|
1991-07-26 |
1993-02-18 |
Frederick L. Moolten |
Traitement anticancereux utilisant des cellules malignes
|
US5240914A
(en)
*
|
1992-02-03 |
1993-08-31 |
Adolph Schwimmer |
Method and compositions for inhibiting tumor cell metabolism
|
US6514949B1
(en)
|
1994-07-11 |
2003-02-04 |
University Of Virginia Patent Foundation |
Method compositions for treating the inflammatory response
|
US6448235B1
(en)
|
1994-07-11 |
2002-09-10 |
University Of Virginia Patent Foundation |
Method for treating restenosis with A2A adenosine receptor agonists
|
US7135584B2
(en)
*
|
1995-08-07 |
2006-11-14 |
Wake Forest University |
Lipid analogs for treating viral infections
|
US5962437A
(en)
*
|
1994-08-29 |
1999-10-05 |
Wake Forest University |
Lipid analogs for treating viral infections
|
US5807874A
(en)
*
|
1995-05-17 |
1998-09-15 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
US5767142A
(en)
*
|
1996-03-20 |
1998-06-16 |
Rutgers, The State University Of New Jersey |
Trisbenzimidazoles useful as topoisomerase I inhibitors
|
US5616575A
(en)
*
|
1995-12-04 |
1997-04-01 |
Regents Of The University Of Minnesota |
Bioactive tricyclic ibogaine analogs
|
US5932553A
(en)
*
|
1996-07-18 |
1999-08-03 |
The Regents Of The University Of California |
Illudin analogs useful as antitumor agents
|
US5723632A
(en)
|
1996-08-08 |
1998-03-03 |
Mgi Pharma, Inc. |
Total synthesis of antitumor acylfulvenes
|
US5922761A
(en)
*
|
1996-09-06 |
1999-07-13 |
Medinox, Inc. |
Methods for in vivo reduction of iron levels and compositions useful therefor
|
CZ102499A3
(cs)
*
|
1996-09-23 |
1999-09-15 |
Rutgers, The State University Of New Jersey |
Heterocyklické sloučeniny a farmaceutický prostředek
|
US5916903A
(en)
*
|
1997-02-28 |
1999-06-29 |
Synapse Pahrmaceuticals International, Inc. |
Method for reducing the effects of antineoplastic disease treatment
|
US5866558A
(en)
*
|
1997-05-08 |
1999-02-02 |
Regents Of The University Of Minnesota |
6-alkynyl steroids
|
US6486214B1
(en)
|
1997-09-10 |
2002-11-26 |
Rutgers, The State University Of New Jersey |
Polyanhydride linkers for production of drug polymers and drug polymer compositions produced thereby
|
US6468519B1
(en)
*
|
1997-09-10 |
2002-10-22 |
Rutgers, The State University Of New Jersey |
Polyanhydrides with biologically active degradation products
|
US6140328A
(en)
|
1997-12-12 |
2000-10-31 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
CA2282461C
(fr)
*
|
1997-12-29 |
2004-04-20 |
John D. Buynak |
Derives d'acide penicillanique 2.beta.-substitue-6-alkylidene utilises comme inhibiteurs de la beta-lactamase
|
US6245808B1
(en)
|
1998-11-05 |
2001-06-12 |
Parker Hughes Institute |
Oxy-vanadium (IV) complexes having spermicidal activity
|
US6051603A
(en)
|
1998-01-20 |
2000-04-18 |
Wayne Hughes Institute |
Vanadium (IV) metallocene complexes having sperm motility inhibiting activity
|
US6432941B1
(en)
*
|
1998-01-20 |
2002-08-13 |
Parker Hughes Institute |
Vanadium compounds for treating cancer
|
IL137351A0
(en)
|
1998-02-12 |
2001-07-24 |
Univ Rutgers |
Heterocyclic topoisomerase poisons
|
US6025328A
(en)
|
1998-02-20 |
2000-02-15 |
The Regents Of The University Of California |
Antitumor agents
|
US7141603B2
(en)
*
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
US6117878A
(en)
*
|
1998-02-24 |
2000-09-12 |
University Of Virginia |
8-phenyl- or 8-cycloalkyl xanthine antagonists of A2B human adenosine receptors
|
US6355678B1
(en)
|
1998-06-29 |
2002-03-12 |
Parker Hughes Institute |
Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
|
US6800649B1
(en)
*
|
1998-06-30 |
2004-10-05 |
Parker Hughes Institute |
Method for inhibiting c-jun expression using JAK-3 inhibitors
|
US6323190B1
(en)
|
1998-07-31 |
2001-11-27 |
The Univeristy Of Georgia Research Foundation, Inc. |
Estrogen mimetics lacking reproductive tract effects
|
US6232297B1
(en)
|
1999-02-01 |
2001-05-15 |
University Of Virginia Patent Foundation |
Methods and compositions for treating inflammatory response
|
US7427606B2
(en)
*
|
1999-02-01 |
2008-09-23 |
University Of Virginia Patent Foundation |
Method to reduce inflammatory response in transplanted tissue
|
US7378400B2
(en)
*
|
1999-02-01 |
2008-05-27 |
University Of Virginia Patent Foundation |
Method to reduce an inflammatory response from arthritis
|
US6166003A
(en)
*
|
1999-02-17 |
2000-12-26 |
Lkt Laboratories, Inc. |
Heterocyclic compounds for cancer chemoprevention
|
WO2000048622A2
(fr)
|
1999-02-22 |
2000-08-24 |
University Of Iowa Research Foundation |
Methode permettant l'inhibition de reactions inflammatoires
|
US6080747A
(en)
*
|
1999-03-05 |
2000-06-27 |
Hughes Institute |
JAK-3 inhibitors for treating allergic disorders
|
DK1159279T3
(da)
|
1999-03-09 |
2003-02-17 |
Upjohn Co |
4-Oxo-4,7-dihydro-thieno[2,3-b]pyridin-5-carboxamider som antivirale midler
|
US7064114B2
(en)
*
|
1999-03-19 |
2006-06-20 |
Parker Hughes Institute |
Gel-microemulsion formulations
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
US6258820B1
(en)
|
1999-03-19 |
2001-07-10 |
Parker Hughes Institute |
Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines
|
US6407091B1
(en)
*
|
1999-04-15 |
2002-06-18 |
Research Corporation Technologies, Inc. |
β-lactamase inhibiting compounds
|
US6930101B1
(en)
|
1999-05-17 |
2005-08-16 |
The Regents Of The University Of California |
Thiazolopyrimidines useful as TNFα inhibitors
|
US6322771B1
(en)
|
1999-06-18 |
2001-11-27 |
University Of Virginia Patent Foundation |
Induction of pharmacological stress with adenosine receptor agonists
|
AU5630800A
(en)
|
1999-06-22 |
2001-01-09 |
Arno F Spatola |
Antimicrobial agents
|
US6946458B2
(en)
|
1999-07-22 |
2005-09-20 |
University Of South Florida |
N-thiolated beta-lactams: novel antibacterial agents for methicillin-resistant Staphylococcus aureus
|
US7151100B1
(en)
*
|
1999-07-23 |
2006-12-19 |
The Regents Of The University Of California |
Indole compounds useful for the treatment of cancer
|
US6852685B1
(en)
|
1999-08-17 |
2005-02-08 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neuronal cell differentiation
|
US6903068B1
(en)
|
1999-08-17 |
2005-06-07 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines
|
US7119064B2
(en)
*
|
1999-08-17 |
2006-10-10 |
Board Of Regents, The University Of Texas System |
Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
|
WO2001012650A2
(fr)
*
|
1999-08-17 |
2001-02-22 |
The University Of Texas System |
Utilisation de la colostrinine, de ses peptides constitutifs, et de ses analogues comme regulateurs du stress oxydatif
|
MY125942A
(en)
|
1999-09-07 |
2006-09-29 |
Upjohn Co |
Aminoalkoxy carbazoles for the treatment of cns diseases
|
US7026469B2
(en)
*
|
2000-10-19 |
2006-04-11 |
Wake Forest University School Of Medicine |
Compositions and methods of double-targeting virus infections and cancer cells
|
US6670341B1
(en)
|
1999-10-28 |
2003-12-30 |
Wake Forest University Health Sciences |
Compositions and methods for double-targeting virus infections and targeting cancer cells
|
US6740650B2
(en)
|
1999-10-29 |
2004-05-25 |
Rutgers, The State University Of New Jersey |
Heterocyclic cytotoxic agents
|
AU1608801A
(en)
|
1999-11-15 |
2001-05-30 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
US6649654B1
(en)
*
|
1999-11-23 |
2003-11-18 |
The Regents Of The University Of California |
Methods for identifying and using IKK inhibitors
|
US6589992B2
(en)
|
1999-11-30 |
2003-07-08 |
Parker Hughes Institute |
Inhibiting collagen-induced platelet aggregation
|
US6685928B2
(en)
|
1999-12-07 |
2004-02-03 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions and methods
|
US20040038948A1
(en)
|
1999-12-07 |
2004-02-26 |
Uhrich Kathryn E. |
Therapeutic compositions and methods
|
EP1252181B1
(fr)
*
|
2000-01-20 |
2006-01-18 |
Regents Of The University Of Minnesota |
Polypeptides possedant une activite therapeutique
|
US6413958B2
(en)
|
2000-03-21 |
2002-07-02 |
Pharmacia & Upjohn Company |
4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents
|
CN1398258A
(zh)
|
2000-03-21 |
2003-02-19 |
法玛西雅厄普约翰美国公司 |
用作抗病毒剂的4-羟基噌啉-3-甲酰胺化合物
|
EP1265895A1
(fr)
|
2000-03-21 |
2002-12-18 |
PHARMACIA & UPJOHN COMPANY |
4-oxo-1,4-dihydro 1,8]naphtyridine-3-carboxamides en tant qu'agents antiviraux
|
US6682892B2
(en)
|
2000-07-13 |
2004-01-27 |
Pharmacia & Upjohn Company |
Method for treating herpes viruses
|
US20040152672A1
(en)
*
|
2000-08-09 |
2004-08-05 |
Carson Dennis A. |
Indole compounds useful for the treatment of cancer
|
US6696441B1
(en)
|
2000-08-11 |
2004-02-24 |
The Regents Of The University Of California |
Inhibition of p53-induced stress response
|
US6951847B2
(en)
*
|
2000-09-29 |
2005-10-04 |
Regents Of The University Of Minnesota |
Methods of treating fungal infections using lupeol
|
AU2001294959A1
(en)
*
|
2000-09-29 |
2002-04-08 |
Robert M. Carlson |
Triterpenes having antibacterial activity
|
CA2424013A1
(fr)
|
2000-09-29 |
2002-04-04 |
Regents Of The University Of Minnesota |
Triterpenes ayant une activite fongicide dirigee contre les levures
|
US7309696B2
(en)
|
2000-10-19 |
2007-12-18 |
Wake Forest University |
Compositions and methods for targeting cancer cells
|
US6958359B1
(en)
*
|
2000-11-15 |
2005-10-25 |
Parker Hughes Institute |
Vanadium compounds as anti-angiogenic agents
|
US6642221B1
(en)
|
2000-11-15 |
2003-11-04 |
Parker Hughes Institute |
Vanadium compounds as anti-proliferative agents
|
US6878388B1
(en)
|
2000-11-15 |
2005-04-12 |
Parker Hughes Institute |
Vanadium compounds for treating proliferative cell disorders
|
AU2002249885A1
(en)
|
2000-11-17 |
2002-08-12 |
Adolor Corporation |
Delta agonist analgesics
|
US20040034045A1
(en)
*
|
2000-11-29 |
2004-02-19 |
Parker Hughes Institute |
Inhibitors of thrombin induced platelet aggregation
|
US7250172B2
(en)
*
|
2001-01-31 |
2007-07-31 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
US7261901B2
(en)
*
|
2001-01-31 |
2007-08-28 |
University Of Iowa Research Foundation |
Vaccine and compositions for the prevention and treatment of neisserial infections
|
US6703524B2
(en)
|
2001-02-20 |
2004-03-09 |
Lkt Laboratories, Inc. |
Organoselenium compounds for cancer chemoprevention
|
US7232829B2
(en)
*
|
2001-04-06 |
2007-06-19 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
GB0111872D0
(en)
*
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
EP1397326A2
(fr)
*
|
2001-05-29 |
2004-03-17 |
Koninklijke Philips Electronics N.V. |
Liaison metal-ceramique
|
US7601846B2
(en)
*
|
2001-06-26 |
2009-10-13 |
The Regents Of The University Of California |
Compounds having activity as inhibitors of apoptosis
|
US20030232794A1
(en)
*
|
2001-06-26 |
2003-12-18 |
Cottam Howard B. |
Use of STAT-6 inhibitors as therapeutic agents
|
JP2005502687A
(ja)
*
|
2001-07-24 |
2005-01-27 |
アラムクス エルエルシー |
β−ラクタマーゼ阻害剤としての7−アルキリデン−3−置換型−3−セフェム−4−カルボキシラート
|
US6753414B2
(en)
*
|
2001-08-07 |
2004-06-22 |
University Of Iowa Research Foundation, Inc. |
Process for preparing saponin compounds
|
MXPA04001203A
(es)
|
2001-08-08 |
2004-05-20 |
Pharmacia & Upjhon Company |
1-h-pirido[4,3-b] indoles terapeuticos.
|
US20030171377A1
(en)
*
|
2001-08-29 |
2003-09-11 |
Bigge Christopher Franklin |
Antidiabetic agents
|
WO2003020728A1
(fr)
|
2001-08-30 |
2003-03-13 |
Pharmacia & Upjohn Company |
Agents antiviraux a base de 4-thioxo-4,7-dihydro-thieno[2,3-b]pyridine-5-carbothioamides
|
WO2003021959A1
(fr)
*
|
2001-08-31 |
2003-03-13 |
Thomson Licensing Sa |
Compteur de sequences destine a un flux audio continu
|
US6887868B2
(en)
*
|
2001-09-21 |
2005-05-03 |
Pharmacia & Upjohn Company |
Therapeutic 5-HT ligand compounds
|
EP1430017A2
(fr)
|
2001-09-26 |
2004-06-23 |
Theravance, Inc. |
Composes phenoliques substitues utiles pour l'anesthesie et la sedation
|
SG176313A1
(en)
*
|
2001-10-01 |
2011-12-29 |
Univ Virginia Patent Found |
2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
|
WO2003031587A2
(fr)
*
|
2001-10-09 |
2003-04-17 |
The Regents Of The University Of California |
Utilisation d'inhibiteurs de stat-6 comme agents therapeutiques
|
DE60238435D1
(de)
*
|
2001-10-26 |
2011-01-05 |
Scripps Research Inst |
Gezielte thrombose durch gewebefaktor polypeptiden
|
EP1453812B1
(fr)
*
|
2001-11-14 |
2008-08-20 |
Rutgers, The State University |
Agents cytotoxiques
|
KR20050044491A
(ko)
|
2001-11-14 |
2005-05-12 |
루트거스, 더 스테이트 유니버시티 |
가용화된 토포이소머라제 독
|
AU2002357762A1
(en)
*
|
2001-11-23 |
2003-06-10 |
Theodore James Anastasion |
Improved synthesis of polyanhyrides
|
US7030141B2
(en)
*
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
JP2005530685A
(ja)
*
|
2002-01-25 |
2005-10-13 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
選択的鎮痛剤
|
US20080026984A1
(en)
*
|
2002-02-04 |
2008-01-31 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
US7968605B2
(en)
*
|
2002-02-04 |
2011-06-28 |
ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. |
Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
|
BR0307420A
(pt)
*
|
2002-02-04 |
2004-12-21 |
Werner Haas |
Compostos, composições farmacêuticas e métodos para impedir e/ou tratar doença em mamìfero
|
US20060057179A1
(en)
|
2002-02-07 |
2006-03-16 |
Giroux Karen J |
Therapeutic polyesters and polyamides
|
WO2003072053A2
(fr)
|
2002-02-22 |
2003-09-04 |
The Curators Of The University Of Missouri |
Composes pour le traitement de la surcharge en cuivre
|
US20050032713A1
(en)
*
|
2002-03-27 |
2005-02-10 |
Wurtman Richard J. |
Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents
|
AU2003224874A1
(en)
*
|
2002-04-04 |
2003-10-27 |
Alamx, L.L.C. |
INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
|
MXPA04010560A
(es)
*
|
2002-04-25 |
2005-08-15 |
Scripps Research Inst |
Tratamiento y prevencion de condiciones pulmonares.
|
US7026472B2
(en)
*
|
2002-05-06 |
2006-04-11 |
University Of South Florida |
Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof
|
US20040156799A1
(en)
*
|
2002-06-04 |
2004-08-12 |
Zigang Dong |
Cancer treatment method and compositions
|
UA79293C2
(en)
*
|
2002-07-03 |
2007-06-11 |
Univ Wayne State |
4-(7'-halo-2-quino (xa-) linyloxy)phenoxy propionic acid derivatives as antineoplastic agents
|
WO2004004640A2
(fr)
*
|
2002-07-05 |
2004-01-15 |
Tetragrammaton Inc. |
Procedes, compositions et trousses destines a traiter un tissu excitable endommage
|
AU2003265406A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Edmond J. Lavoie |
Nitro and amino substituted topoisomerase agents
|
WO2004024679A1
(fr)
*
|
2002-09-11 |
2004-03-25 |
Warner-Lambert Company Llc |
Inhibiteurs de facteur xa et autres serine proteases intervenant dans la cascade de coagulation
|
US7211599B2
(en)
*
|
2002-09-19 |
2007-05-01 |
The Regents Of The University Of California |
Use of etodolac to treat hyperplasia
|
EP2447278B1
(fr)
|
2002-10-10 |
2015-04-08 |
Cornell Research Foundation, Inc. |
Nouvelles protéines immunogènes de Leptospira
|
US20060183106A1
(en)
*
|
2002-10-18 |
2006-08-17 |
Adam Siddiqui-Jain |
Processes for identifying quadruplex-targeted antiviral molecules
|
EP1567551A4
(fr)
*
|
2002-10-22 |
2008-03-12 |
Univ Texas |
Colostrinine et peptides de celle-ci utilises en tant que modulateurs de molecules de signalisation intracellulaire et inhibiteurs de l'apoptose
|
WO2004039362A2
(fr)
*
|
2002-10-28 |
2004-05-13 |
Paraquest, Inc. |
Hypoestoxydes, derives et agonistes de ces derniers a utiliser dans le traitement et la prophylaxie d'hyperlipidemies
|
EP3299393A1
(fr)
|
2002-11-08 |
2018-03-28 |
Ablynx N.V. |
Anticorps à domaine unique dirigés contre le facteur alpha de la nécrose tumorale et leurs utilisations
|
EP1558650A2
(fr)
|
2002-11-08 |
2005-08-03 |
Ablynx N.V. |
Procede d'administration de polypeptides therapeutiques et polypeptides associes
|
GB2395432B
(en)
*
|
2002-11-20 |
2005-09-14 |
Northwick Park Inst For Medica |
Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
|
WO2004047800A2
(fr)
*
|
2002-11-26 |
2004-06-10 |
Gilead Sciences, Inc. |
Procede de chargement de medicament dans des liposomes par gradient
|
WO2004053099A2
(fr)
*
|
2002-12-10 |
2004-06-24 |
The Scripps Research Institute |
Methode de traitement de pharmacodependance et de criblage d'agents pharmaceutiques utiles pour ledit traitement
|
US8119854B2
(en)
*
|
2002-12-10 |
2012-02-21 |
Pietro P. Sanna |
Role of proteoglycans in drug dependence
|
WO2004062583A2
(fr)
*
|
2003-01-07 |
2004-07-29 |
University Of Iowa Research Foundation |
Vaccin et procede de prevention de la formation d'un film biologique
|
NZ540771A
(en)
|
2003-01-10 |
2009-05-31 |
Ablynx Nv |
Recombinant VHH single domain antibody from camelidae against von willebrand factor (vWF) or against collagen
|
US20070207217A1
(en)
*
|
2003-02-03 |
2007-09-06 |
Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda |
Method for treating a mammal by administration of a compound having the ability to release CO
|
US20050079512A1
(en)
*
|
2003-02-26 |
2005-04-14 |
Emerson Beverly M. |
Methods of modulating gene expression
|
WO2004087672A1
(fr)
|
2003-03-28 |
2004-10-14 |
Cornell Research Foundation, Inc. |
Compositions de substances analogues a la migrastatine et leurs utilisations
|
US7163948B2
(en)
*
|
2003-04-07 |
2007-01-16 |
Cylene Pharmaceuticals, Inc. |
Heterocyclic substituted 1,4-dihydri-4ox9-1,8-naphthyridine analogs
|
KR100944600B1
(ko)
*
|
2003-04-07 |
2010-02-25 |
사일린 파마슈티칼스, 인크 |
치환된 퀴노벤족사진 유사체
|
US7354916B2
(en)
*
|
2003-04-07 |
2008-04-08 |
Cylene Pharmaceuticals |
Substituted quinobenzoxazine analogs
|
US7507727B2
(en)
*
|
2003-04-07 |
2009-03-24 |
Cylene Pharmaceuticals, Inc. |
Substituted quinobenzoxazine analogs and methods of using thereof
|
US20040248880A1
(en)
*
|
2003-04-25 |
2004-12-09 |
Jacobsen Eric Jon |
1,2,3,4,5,6-Hexahydroazepino[4,5-B]indoles containing arylsulfones at the 9-position
|
CA2536357A1
(fr)
*
|
2003-05-29 |
2004-12-23 |
The Scripps Research Institute |
Liberation ciblee sur des cellules exprimant la legumaine
|
WO2005009434A2
(fr)
|
2003-06-25 |
2005-02-03 |
The Burnham Institute |
Procedes et composes servant a provoquer l'apoptose dans des cellules cancereuses
|
WO2005003140A1
(fr)
*
|
2003-07-02 |
2005-01-13 |
Pharmacia & Upjohn Company Llc |
4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides utilises comme agents antiviraux
|
PL1658291T3
(pl)
|
2003-08-25 |
2014-03-31 |
Dogwood Pharmaceuticals Inc |
Podstawione 8-heteroaryloksantyny
|
PL2520654T3
(pl)
|
2003-08-26 |
2017-08-31 |
The Regents Of The University Of Colorado, A Body Corporate |
Inhibitory aktywności proteazy serynowej i ich zastosowanie w sposobach i kompozycjach do leczenia zakażeń bakteryjnych
|
US9532994B2
(en)
|
2003-08-29 |
2017-01-03 |
The Regents Of The University Of California |
Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
|
WO2005042699A2
(fr)
*
|
2003-10-17 |
2005-05-12 |
Regents Of The University Of Minnesota |
Polypeptides modifies presentant une activite therapeutique et leurs methodes d'utilisation
|
DE60334645D1
(de)
|
2003-11-07 |
2010-12-02 |
Ablynx Nv |
Camelidae schwere ketten antikörper vhhs gegen epidermalen wachstumfaktor rezeptor (egfr) und ihre verwendung
|
CA2549160A1
(fr)
*
|
2003-12-04 |
2005-06-23 |
The Scripps Research Institute |
Traitement et preventions de l'asthme
|
AU2004305075A1
(en)
*
|
2003-12-19 |
2005-07-07 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies
|
NZ589967A
(en)
|
2004-01-14 |
2012-07-27 |
Gilead Sciences Inc |
Lipid-based dispersions useful for drug delivery
|
WO2005072766A2
(fr)
*
|
2004-01-27 |
2005-08-11 |
Boys Town National Research Hospital |
Peptides se liant aux proteines hsp90
|
US8841326B2
(en)
|
2004-02-12 |
2014-09-23 |
Stc.Unm |
Therapeutic curcumin derivatives
|
US20050187191A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Louis S. |
Methods and compositions for the treatment of respiratory syncytial virus
|
US20050187192A1
(en)
*
|
2004-02-20 |
2005-08-25 |
Kucera Pharmaceutical Company |
Phospholipids for the treatment of infection by togaviruses, herpes viruses and coronaviruses
|
AU2005232526B2
(en)
*
|
2004-02-24 |
2011-06-23 |
The Regents Of The University Of California |
Methods and materials for assessing prostate cancer therapies and compounds
|
ES2629682T3
(es)
|
2004-03-29 |
2017-08-14 |
University Of South Florida |
Tratamiento efectivo de tumores y cáncer con fosfato de triciribina
|
US8957056B2
(en)
*
|
2004-05-25 |
2015-02-17 |
Sloan-Kettering Instiute For Cancer Research |
Migrastatin analogs in the treatment of cancer
|
EP1778712B1
(fr)
*
|
2004-08-02 |
2013-01-30 |
University Of Virginia Patent Foundation |
Analogues de 2-propynyle adenosine comprenant des groupes 5'-ribose modifies presentant une activite agoniste a2a
|
WO2006023272A1
(fr)
*
|
2004-08-02 |
2006-03-02 |
University Of Virginia Patent Foundation |
Analogues de 2-polycyclique propynyle adenosine presentant une activite agoniste de a2a
|
WO2006028618A1
(fr)
*
|
2004-08-02 |
2006-03-16 |
University Of Virginia Patent Foundation |
Analogues d'adenosine de propynyle 2-polycyclique presentant des groupes 5'-ribose modifies presentant une activite agoniste de a2a
|
WO2006026380A2
(fr)
*
|
2004-08-25 |
2006-03-09 |
University Of Iowa Research Foundation |
Inhibiteurs de la geranylgeranyl pyrophosphate synthase
|
US20080213345A1
(en)
*
|
2004-09-13 |
2008-09-04 |
Gilead Sciences, Inc. |
Delivering Iron to an Animal
|
US7718680B2
(en)
*
|
2004-09-23 |
2010-05-18 |
Burnham Institute For Medical Research |
Inhibition of lethal factor protease activity from anthrax toxin
|
CA2582766C
(fr)
*
|
2004-09-23 |
2014-07-22 |
Sloan-Kettering Institute For Cancer Research |
Analogues d'isomigrastatine utilises dans le traitement du cancer
|
AU2005293752A1
(en)
*
|
2004-10-13 |
2006-04-20 |
Ablynx N.V. |
Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as Alzheimer's disease
|
US8697674B2
(en)
*
|
2004-12-29 |
2014-04-15 |
Naturon, Inc. |
Xanthurenic acid derivative pharmaceutical compositions and methods related thereto
|
WO2006086103A2
(fr)
*
|
2005-01-10 |
2006-08-17 |
University Of Virginia Patent Foundation |
Synthese d'inhibiteurs de p90rsk
|
US7691364B2
(en)
|
2005-01-28 |
2010-04-06 |
Bezwada Biomedical, Llc |
Functionalized drugs and polymers derived therefrom
|
US7709517B2
(en)
*
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
PL2444085T3
(pl)
|
2005-05-13 |
2015-07-31 |
Univ California |
Związki diarylohydantoinowe jako antagoniści receptora androgenów do leczenia raka
|
MX363423B
(es)
|
2005-05-18 |
2019-03-22 |
Ablynx Nv |
Nanobodiestm (nanocuerpos) mejorados contra el factor alfa de necrosis del tumor.
|
EP2444424B1
(fr)
|
2005-05-20 |
2018-08-08 |
Ablynx N.V. |
Nano-corps améliorés (tm) pour le traitement des troubles liés à l'agrégation
|
US20070025910A1
(en)
*
|
2005-07-29 |
2007-02-01 |
Norenberg Jeffrey P |
Anticancer therapy
|
ATE527998T1
(de)
*
|
2005-08-03 |
2011-10-15 |
Univ California |
Illudin-analoga als krebsmittel
|
CA2620182A1
(fr)
|
2005-08-22 |
2007-03-01 |
Dennis A. Carson |
Agonistes tlr
|
CA2618970C
(fr)
|
2005-08-29 |
2015-03-31 |
University Of Virginia Patent Foundation |
Analogues d'une lisofylline et procedes d'utilisation de ceux-ci
|
US8871764B2
(en)
|
2005-08-29 |
2014-10-28 |
University Of Virginia Patent Foundation |
Lisofylline analogs and methods for use
|
WO2007053794A2
(fr)
|
2005-10-21 |
2007-05-10 |
Bezwada Biomedical Llc |
Composés phénoliques fonctionnalisés et dispositifs absorbables fabriqués à partir desdits composés
|
US20090291437A1
(en)
*
|
2005-11-02 |
2009-11-26 |
O'brien Sean |
Methods for targeting quadruplex sequences
|
WO2007064759A2
(fr)
*
|
2005-11-29 |
2007-06-07 |
The Scripps Research Institute |
Inhibition de l'invasion des cellules tumorales, de la metastase et de l'angiogenese
|
US8007526B2
(en)
|
2005-12-01 |
2011-08-30 |
Bezwada Biomedical, Llc |
Difunctionalized aromatic compounds and polymers therefrom
|
WO2007078615A2
(fr)
*
|
2005-12-15 |
2007-07-12 |
Cavit Sciences, Inc |
Procédés et compositions de traitement du cancer
|
US20070244057A1
(en)
*
|
2006-01-20 |
2007-10-18 |
Henry Paulson |
Suppressing polyglutamine aggregation and toxicity
|
GB0601394D0
(en)
|
2006-01-24 |
2006-03-01 |
Hemocorm Ltd |
Therapeutic delivery of carbon monoxide
|
US7615649B2
(en)
|
2006-01-26 |
2009-11-10 |
Iowa State University Research Foundation, Inc, |
Synthesis of polycyclic procyanidins
|
WO2007120972A2
(fr)
*
|
2006-02-10 |
2007-10-25 |
University Of Virginia Patent Foundation |
Procede permettant de traiter l'anemie a hematies falciformes
|
US20080009545A1
(en)
*
|
2006-02-21 |
2008-01-10 |
The Ohio State University Research Foundation |
Anticancer agents
|
WO2007098281A2
(fr)
|
2006-02-27 |
2007-08-30 |
Regents Of The University Of California |
Composés oxystérols et voie
|
JP5503874B2
(ja)
|
2006-02-28 |
2014-05-28 |
ダート ニューロサイエンス (ケイマン) エルティーディー |
治療化合物
|
CN101431996A
(zh)
*
|
2006-03-22 |
2009-05-13 |
加利福尼亚大学董事会 |
蛋白质异戊二烯基转移酶的抑制剂
|
EP2656842B1
(fr)
|
2006-03-27 |
2016-08-10 |
The Regents of The University of California |
Modulateur de récepteur androgène pour le traitement du cancer de la prostate et de maladies associées au récepteur androgène
|
CA2648139A1
(fr)
|
2006-03-29 |
2007-11-08 |
The Regents Of The University Of California |
Composes de diarylthiohydantoine et leur utilisation dans le traitement de troubles d'hyperproliferation
|
US8093235B2
(en)
|
2006-04-25 |
2012-01-10 |
Rutgers, The State University Of New Jersey |
Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
|
US8426568B2
(en)
*
|
2006-05-22 |
2013-04-23 |
University Of Virginia Patent Foundation |
Rhamnose substituents of SL0101 and therapeutic uses thereof
|
US8846697B2
(en)
|
2006-05-31 |
2014-09-30 |
The Regents Of The University Of California |
Purine analogs
|
WO2007143081A2
(fr)
*
|
2006-06-02 |
2007-12-13 |
The Ohio State University Research Foundation |
Agents thérapeutiques destinés au traitement de malignités lymphoïdes
|
US20110112086A1
(en)
*
|
2006-06-08 |
2011-05-12 |
Cylene Pharmaceuticals, Inc. |
Pyridinone analogs
|
US20100305136A1
(en)
*
|
2006-06-08 |
2010-12-02 |
Johnny Yasuo Nagasawa |
Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
|
UA105164C2
(en)
|
2006-06-16 |
2014-04-25 |
Догвуд Фармасьютикалз, Инк |
Substituted 8-[6-amino-3-pyridyl]xanthines
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
EP2102144A4
(fr)
|
2006-09-13 |
2011-03-23 |
Univ Rutgers |
Agents actifs et oligomères et polymères de ceux-ci
|
WO2008036244A1
(fr)
*
|
2006-09-18 |
2008-03-27 |
The Burham Institute For Medical Research |
Utilisation de cyclosporine a pour sensibiliser des cellules cancéreuses résistantes à des ligands de récepteur de mort
|
CA2666461A1
(fr)
*
|
2006-10-10 |
2008-09-12 |
Burnham Institute For Medical Research |
Compositions neuroprotectrices et procedes correspondants
|
US8034829B2
(en)
|
2006-11-17 |
2011-10-11 |
Rexahn Pharmaceuticals, Inc. |
5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof
|
EP2086962A1
(fr)
*
|
2006-11-29 |
2009-08-12 |
Pfizer Products Inc. |
1- [ ( 4 -chlorophényl) amide 5-{[2-fluoro-4- (2-oxo-2h-pyridin-1-yl) -phényl]amide) d'acide (r) -5-méthyl-4, 5-dihydro- pyrazole-1, 5-dicarboxylique servant d'inhibiteur du facteur xa
|
CA2672965C
(fr)
|
2006-12-19 |
2018-02-06 |
Ablynx N.V. |
Sequences d'acides amines dirigees contre une metalloproteinase de la famille adam et polypeptides les comprenant a des fins de traitement de maladies et troubles lies a adam
|
AU2007336242B2
(en)
|
2006-12-19 |
2012-08-30 |
Ablynx N.V. |
Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
|
JP2010518108A
(ja)
|
2007-02-06 |
2010-05-27 |
ユニバーシティ オブ ルーイビル リサーチ ファウンデーション,インコーポレーテッド |
治療化合物
|
PL2510946T3
(pl)
|
2007-02-07 |
2015-12-31 |
Univ California |
Koniugaty syntetycznych agonistów tlr i ich zastosowania
|
WO2008103818A1
(fr)
*
|
2007-02-21 |
2008-08-28 |
University Of Louisville Research Foundation |
Compositions thérapeutiques à base de cotinine
|
CA2679301C
(fr)
|
2007-02-28 |
2015-08-11 |
University Of Virginia Patent Foundation |
Analogues de lisofylline et procedes d'utilisation en matiere de protection des cellules beta pancreatiques, de traitement du diabete de type 1 et de traitement des maladies inflammatoires et auto-immunes
|
WO2008138001A2
(fr)
|
2007-05-08 |
2008-11-13 |
University Of Louisville Research Foundation |
Peptides synthétiques et mimétiques peptidiques
|
EP2173352B1
(fr)
*
|
2007-07-12 |
2016-09-07 |
University of South Florida |
Inhibiteurs de akt/pkb à activité antitumorale
|
EP2185568A4
(fr)
|
2007-08-02 |
2010-08-11 |
Trustees Rutgers The State Uni |
Composés thérapeutiques
|
US20090087497A1
(en)
*
|
2007-08-16 |
2009-04-02 |
Burnham Institute For Medical Research |
Compositions and methods for treating symptoms of aging
|
CN101820764B
(zh)
|
2007-08-27 |
2014-06-04 |
海利空医疗公司 |
治疗用异噁唑化合物
|
US8217134B2
(en)
|
2007-08-30 |
2012-07-10 |
Bezwada Biomedical, Llc |
Controlled release of biologically active compounds
|
US8048980B2
(en)
|
2007-09-17 |
2011-11-01 |
Bezwada Biomedical, Llc |
Hydrolysable linkers and cross-linkers for absorbable polymers
|
MX2010003685A
(es)
*
|
2007-10-05 |
2010-06-02 |
Cylene Pharmaceuticals Inc |
Analogos de quinolona y metodos relacionados con los mismos.
|
US9115061B2
(en)
*
|
2007-10-19 |
2015-08-25 |
Burnham Institute For Medical Research |
Naphthalene-based inhibitors of anti-apoptotic proteins
|
WO2009055677A1
(fr)
*
|
2007-10-24 |
2009-04-30 |
University Of South Florida |
Disulfures s-hétérosubstitués antibactériens
|
UY31432A1
(es)
|
2007-10-26 |
2009-05-29 |
|
Compuestos de diarilhidantoina
|
US7951832B2
(en)
*
|
2007-10-31 |
2011-05-31 |
Burnham Institute For Medical Research |
Pyrazole derivatives as kinase inhibitors
|
JP2011505357A
(ja)
|
2007-12-03 |
2011-02-24 |
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア |
ヘッジホッグシグナル伝達、骨誘導、抗脂肪生成、及びwntシグナル伝達を活性するためのオキシステロール
|
US8058259B2
(en)
*
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
KR20100137449A
(ko)
*
|
2008-02-07 |
2010-12-30 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
Tlr7 활성화제를 사용한 방광 질환의 치료
|
WO2009108716A2
(fr)
|
2008-02-27 |
2009-09-03 |
University Of Louisville Research Foundation |
Peptides synthétiques
|
WO2009114539A2
(fr)
*
|
2008-03-10 |
2009-09-17 |
University Of Louisville Research Foundation |
Traitements neuroprotecteurs à base de peptide de liaison de l'intégrine et de l'angiopoïétine-1
|
WO2009114921A1
(fr)
*
|
2008-03-17 |
2009-09-24 |
Dmitrienko Gary I |
INHIBITEURS DE β-LACTAMASES DE CLASSE B ET DE CLASSE D
|
WO2009146112A1
(fr)
*
|
2008-04-02 |
2009-12-03 |
University Of Virginia Patent Foundation |
Compositions et procédés pour inhiber la sphingosine kinase
|
EP2947097A1
(fr)
|
2008-04-07 |
2015-11-25 |
Ablynx N.V. |
Séquences d'acides aminés dirigées contre les voies Notch et leurs utilisations
|
JP6034023B2
(ja)
|
2008-05-16 |
2016-11-30 |
アブリンクス エン.ヴェー. |
Cxcr4及び他のgpcrに指向性を有するアミノ酸配列及びそれを含む化合物
|
US9872867B2
(en)
*
|
2008-06-06 |
2018-01-23 |
Tanya Kuritz |
Methods and compositions for modulation of innate immunity
|
EP2299809B1
(fr)
|
2008-06-17 |
2018-10-17 |
Ben Gurion University Of The Negev R&D Authority |
Composés de cyclohexylidène-éthylidène-octahydro-indène substitués
|
US8673910B2
(en)
*
|
2008-06-30 |
2014-03-18 |
H. Lee Moffitt Cancer Center And Research Institute |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
US7947717B2
(en)
*
|
2008-07-18 |
2011-05-24 |
Burnham Institute For Medical Research |
Inhibitors of lethal factor protease
|
US9125821B2
(en)
|
2008-07-28 |
2015-09-08 |
The Regents Of The University Of California |
Nanodrug targeting protein geranylgeranylation
|
WO2010014054A1
(fr)
*
|
2008-07-28 |
2010-02-04 |
The Regents Of The University Of California |
Inhibiteurs de prényltransférases de protéine
|
MX2011001486A
(es)
|
2008-08-05 |
2011-05-02 |
Univ South Florida |
El uso de mediadores inflamatorios en el tratamiento del deterioro cognotivo.
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
AU2009279400A1
(en)
*
|
2008-08-08 |
2010-02-11 |
University Of Florida Research Foundation, Inc. |
Lipid compounds for supression of tumorigenesis
|
US9801865B2
(en)
|
2008-09-24 |
2017-10-31 |
The United States Of America As Represented By The Department Of Veteran Affairs |
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
|
US8124654B2
(en)
*
|
2008-11-11 |
2012-02-28 |
Immune Modulation, Inc. |
Derivatives of hypoestoxide and related compounds
|
TW201038578A
(en)
|
2009-01-30 |
2010-11-01 |
Univ Rutgers |
Methods to treat cancer
|
WO2010088924A1
(fr)
|
2009-02-06 |
2010-08-12 |
Telormedix Sa |
Compositions pharmaceutiques comprenant des imidazoquinolines (amines) et des dérivés de celles-ci appropriés pour une administration locale
|
US8729088B2
(en)
*
|
2009-02-11 |
2014-05-20 |
The Regents Of The University Of California |
Toll-like receptor modulators and treatment of diseases
|
EP2403856B1
(fr)
|
2009-03-06 |
2012-12-19 |
Rutgers, The State University of New Jersey |
Dérivés de méthylènedioxybenzo [i]phénanthridine pour traiter le cancer
|
CA2755975A1
(fr)
|
2009-03-20 |
2010-09-23 |
University Of Iowa Research Foundation |
Bisphosphonates prenyles en tant qu'agents antituberculeux
|
CA2758191C
(fr)
|
2009-04-10 |
2015-06-30 |
Ablynx N.V. |
Sequences d'acides amines ameliorees directement contre il-6r et polypeptides comprenant celles-ci pour le traitement de maladies et de troubles associes a il-6r
|
CA2758491A1
(fr)
|
2009-04-15 |
2010-10-21 |
Sanford-Burnham Medical Research Institute |
Inhibiteurs de proteines anti-apoptotiques a base de naphtalene
|
US8487131B2
(en)
|
2009-04-15 |
2013-07-16 |
Sanford-Burnham Medical Research Institute |
Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
|
US20120108823A1
(en)
|
2009-04-22 |
2012-05-03 |
The Ohio State University Research Foundation |
Anti-francisella agents
|
US8906965B2
(en)
|
2009-05-11 |
2014-12-09 |
The University Of Tennessee Research Foundation |
Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation
|
EP2430016B1
(fr)
|
2009-05-13 |
2020-04-01 |
University Of Virginia Patent Foundation |
Inhibiteurs de leucémie inv(16)
|
US8263762B2
(en)
|
2009-06-30 |
2012-09-11 |
Dogwood Pharmaceuticals, Inc. |
Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists
|
WO2011005871A1
(fr)
|
2009-07-07 |
2011-01-13 |
Pgxhealth, Llc |
8-[6-carbonylamino-3-pyridyle] xanthines substituées en tant quantagonistes de ladénosine a2b
|
SG177557A1
(en)
|
2009-07-09 |
2012-02-28 |
Cbt Dev Ltd |
Combined preparation for use as a medicament
|
KR20120085738A
(ko)
|
2009-07-31 |
2012-08-01 |
바이오크리스트파마슈티컬즈,인코포레이티드 |
야누스 키나제 억제제로서의 피롤로 [1,2-b] 피리다진 유도체
|
WO2011019995A2
(fr)
|
2009-08-14 |
2011-02-17 |
Hecht Sidney M |
Synthèse et identification de nouveaux inhibiteurs spécifiques de la rsk
|
TW201111385A
(en)
|
2009-08-27 |
2011-04-01 |
Biocryst Pharm Inc |
Heterocyclic compounds as janus kinase inhibitors
|
US8642088B2
(en)
|
2009-09-04 |
2014-02-04 |
Wisconsin Alumni Research Foundation |
Tannin-chitosan composites
|
US8993535B2
(en)
|
2009-09-04 |
2015-03-31 |
Merck Sharp & Dohme Corp. |
Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
|
EA201270347A1
(ru)
*
|
2009-10-08 |
2012-11-30 |
Санфорд-Бернхам Медикал Ресерч Инститъют |
Производные апогоссиполона в качестве противоопухолевых агентов
|
CA2780145A1
(fr)
|
2009-11-05 |
2011-05-12 |
Rutgers, The State University Of New Jersey |
Composes therapeutiques
|
WO2011069075A2
(fr)
|
2009-12-04 |
2011-06-09 |
Grant Jon E |
Traitement de troubles du contrôle des impulsions au moyen d'inhibiteurs de la catéchol-o-méthyltransférase
|
EP2516444A2
(fr)
|
2009-12-23 |
2012-10-31 |
Biocryst Pharmaceuticals, Inc. |
Composés hétérocycliques comme inhibiteurs de la janus kinase
|
US9096544B2
(en)
|
2009-12-23 |
2015-08-04 |
Wayne State University |
Therapeutic compounds
|
EA201792046A1
(ru)
|
2010-02-16 |
2018-05-31 |
Арагон Фармасьютикалс, Инк. |
Модуляторы рецептора андрогенов и их применение
|
CA2828114A1
(fr)
|
2010-02-26 |
2011-09-01 |
Gary Igor DMITRIENKO |
Derives de la cephalosporine utiles comme inhibiteurs de la .beta.-lactamase et leurs compositions et procedes d'utilisation
|
WO2011123416A1
(fr)
|
2010-03-29 |
2011-10-06 |
Surmodics, Inc. |
Formulation injectable pour l'administration de médicaments
|
EP2552885A1
(fr)
|
2010-04-02 |
2013-02-06 |
TSRL, Inc. |
Inhibiteurs de la neuraminidase
|
WO2011127344A2
(fr)
|
2010-04-08 |
2011-10-13 |
University Of Virginia Patent Foundation |
Méthode de détection et de traitement d'une diarrhée infectieuse ou inflammatoire
|
WO2011130740A2
(fr)
|
2010-04-16 |
2011-10-20 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Urées à base de pyridylthiazole utilisées comme inhibiteurs des protéines kinases associées à rho (rock), et leurs procédés d'utilisation
|
WO2011133696A2
(fr)
|
2010-04-20 |
2011-10-27 |
Regents Of The University Of Minnesota |
Méthodes de lutte contre l'athérosclérose
|
WO2011150356A1
(fr)
|
2010-05-28 |
2011-12-01 |
Biocryst Pharmaceuticals, Inc. |
Composés hétérocycliques en tant qu'inhibiteurs de janus kinase
|
WO2011156626A1
(fr)
|
2010-06-09 |
2011-12-15 |
Rutgers, The State University Of New Jersey |
Agents antimicrobiens
|
CA2803890A1
(fr)
|
2010-06-25 |
2011-12-29 |
Rutgers, The State University Of New Jersey |
Agents antimicrobiens
|
US8741317B2
(en)
|
2010-08-19 |
2014-06-03 |
Rutgers, The State University Of New Jersey |
Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
|
WO2012027494A1
(fr)
|
2010-08-24 |
2012-03-01 |
Regents Of The University Of Minnesota |
Réactifs bispécifiques de ciblage
|
US20120083473A1
(en)
|
2010-09-21 |
2012-04-05 |
Johanna Holldack |
Treatment of conditions by toll-like receptor modulators
|
WO2012061120A1
(fr)
|
2010-10-25 |
2012-05-10 |
Regents Of The University Of Minnesota |
Composition thérapeutique pour le traitement du glioblastome
|
WO2012058665A1
(fr)
|
2010-10-29 |
2012-05-03 |
University Of Connecticut |
Compositions et procédés pour modulation et détection de réponses immunitaires et inflammatoires
|
EP2635274B1
(fr)
|
2010-11-01 |
2017-12-06 |
The Ohio State University Research Foundation |
Dérivés de célécoxib anti-staphylocoque
|
EP2646553A4
(fr)
|
2010-11-12 |
2015-01-07 |
Santaris Pharma As |
Compositions et procédés pour le traitement de troubles dépendant des récepteurs androgènes y compris les cancers
|
US8309768B2
(en)
|
2010-11-29 |
2012-11-13 |
The Ohio State University Research Foundation |
FTY720-derived anticancer agents
|
US8546397B2
(en)
|
2010-12-20 |
2013-10-01 |
The Ohio State University Research Foundation |
DNA methylation inhibitors
|
US8933119B2
(en)
|
2011-01-03 |
2015-01-13 |
The William M. Yarbrough Foundation |
Method for treating phytophotodermatitis
|
US9962361B2
(en)
|
2011-01-03 |
2018-05-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US11279674B2
(en)
|
2011-01-03 |
2022-03-22 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
US10647668B2
(en)
|
2011-01-03 |
2020-05-12 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactant and associated method of use
|
US10640464B2
(en)
|
2011-01-03 |
2020-05-05 |
The William M. Yarbrough Foundation |
Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases
|
US10273205B2
(en)
|
2011-01-03 |
2019-04-30 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
|
US10308599B2
(en)
|
2011-01-03 |
2019-06-04 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US11407713B2
(en)
|
2011-01-03 |
2022-08-09 |
The William M. Yarbrough Foundation |
Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use
|
US8865765B2
(en)
|
2011-01-12 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating eczema
|
WO2012109108A1
(fr)
|
2011-02-07 |
2012-08-16 |
Biogen Idec Ma Inc. |
Agents modulant s1p
|
US9532969B2
(en)
|
2011-02-08 |
2017-01-03 |
The William M. Yarbrough Foundation |
Method for treating psoriasis
|
EP2683837A2
(fr)
|
2011-03-07 |
2014-01-15 |
University Of Louisville Research Foundation, Inc. |
Marqueur prédictif de l'efficacité thérapeutique de l'inhibiteur dnmt1, et procédés d'utilisation dudit marqueur
|
US9616064B2
(en)
|
2011-03-30 |
2017-04-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Rho kinase inhibitors and methods of use
|
KR20140027211A
(ko)
|
2011-04-04 |
2014-03-06 |
유니버시티 오브 아이오와 리써치 파운데이션 |
백신 면역원성의 개선 방법
|
WO2012139015A1
(fr)
|
2011-04-06 |
2012-10-11 |
Rutgers, The State University Of New Jersey |
Polymères et procédés pour le traitement de la douleur
|
WO2012145520A2
(fr)
|
2011-04-19 |
2012-10-26 |
Alfama, Inc. |
Molécules libérant du monoxyde de carbone et utilisations de celles-ci
|
WO2012145678A1
(fr)
|
2011-04-20 |
2012-10-26 |
Regents Of The University Of Minnesota |
Composés parthénolides anticancéreux et anti-inflammatoire
|
WO2012177770A1
(fr)
|
2011-06-20 |
2012-12-27 |
Rutgers, The State University Of New Jersey |
Inhibiteurs bipartites de l'arn polymérase bactérienne
|
US9133230B2
(en)
|
2011-06-21 |
2015-09-15 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Hydrazone derivatives having potent antitumor activity toward multi-drug resistant tumor cells
|
EP2729483A1
(fr)
|
2011-07-08 |
2014-05-14 |
Regents Of The University Of Minnesota |
Analogues du glutathion et leurs utilisations
|
ES2628634T3
(es)
|
2011-07-21 |
2017-08-03 |
Alfama, Inc. |
Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
|
AU2012287103B2
(en)
|
2011-07-22 |
2017-03-30 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
MX359664B
(es)
|
2011-07-29 |
2018-10-05 |
Univ Colorado Regents |
Tratamiento de cáncer de mama.
|
WO2013025936A1
(fr)
|
2011-08-18 |
2013-02-21 |
Cornell University |
Détection et traitement d'une maladie métastatique
|
WO2013028866A1
(fr)
|
2011-08-24 |
2013-02-28 |
Regents Of The University Of Minnesota |
Composés et méthodes thérapeutiques
|
US9034336B2
(en)
|
2011-08-30 |
2015-05-19 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
EP2750508A4
(fr)
|
2011-08-30 |
2015-01-14 |
Univ Wayne State |
Composés et procédés thérapeutiques
|
CA2846676C
(fr)
|
2011-09-08 |
2020-06-23 |
Western University Of Health Sciences |
Liposomes cibles en therapie cancereuse
|
JP2014527083A
(ja)
|
2011-09-15 |
2014-10-09 |
アリゾナ ボード オブ リージェンツ, ア ボディー コーポレイト オブ ザ ステート オブ アリゾナ, アクティング フォー アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティー |
治療用化合物
|
DK2773325T3
(en)
*
|
2011-11-04 |
2019-01-14 |
Enceladus Pharmaceuticals B V |
LIPOSOMAL CORTICOSTEROIDS FOR TREATMENT OF INFLAMMATORY DISORDERS BY HUMANS
|
WO2013101719A2
(fr)
*
|
2011-12-27 |
2013-07-04 |
Northeast Ohio Medical University |
Composés et analogues d'amooranine et procédés d'utilisation associés
|
US9517994B2
(en)
|
2012-01-05 |
2016-12-13 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: phloroglucinol derivatives
|
CA2862999A1
(fr)
|
2012-01-11 |
2013-07-18 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona Acting For And On Behalf Of Arizona State University |
Fragments d'anticorps bispecifiques pour proteines associees a une maladie neurologique, et procedes d'utilisation
|
WO2013106756A2
(fr)
|
2012-01-13 |
2013-07-18 |
Rutgers, The State University Of New Jersey |
Agents antimicrobiens
|
US9333242B2
(en)
|
2012-01-19 |
2016-05-10 |
Hybrid Medical, Llc |
Topical therapeutic formulations
|
US9296728B2
(en)
|
2012-01-20 |
2016-03-29 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
US9488664B2
(en)
|
2012-01-25 |
2016-11-08 |
Sbi Pharmaceuticals Co., Ltd. |
Diagnostic agent for tumor
|
US20130195752A1
(en)
|
2012-02-01 |
2013-08-01 |
Regents Of The University Of Minnesota |
Functionalized nanoparticles and methods of use thereof
|
CA2863427C
(fr)
|
2012-02-01 |
2022-07-12 |
The Governors Of The University Of Alberta |
Utilisation de pdgfr-alpha en tant que marqueur de diagnostic pour le cancer de la thyroide papillaire
|
US9839634B2
(en)
|
2012-02-06 |
2017-12-12 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: combination of a rifamycin and a switch region inhibitor
|
WO2013119946A1
(fr)
|
2012-02-08 |
2013-08-15 |
Of Virginia Patent Foundation University |
Inhibiteurs de la kinase sphingosine avec base à longue chaîne
|
WO2013131089A2
(fr)
|
2012-03-02 |
2013-09-06 |
The Board Of Trustees Of The University Of Illinois |
Activité anticancéreuse puissante par activation d'un composé double
|
AU2013230985B2
(en)
|
2012-03-06 |
2016-05-12 |
The Board Of Trustees Of The University Of Illinois |
Procaspase combination therapy for glioblastoma
|
WO2013142712A1
(fr)
|
2012-03-21 |
2013-09-26 |
Rutgers, The State University Of New Jersey |
Agents anti-microbiens
|
WO2013142812A1
(fr)
|
2012-03-22 |
2013-09-26 |
Rutgers, The State University Of New Jersey |
Agents antibactériens : dérivés de myxopyronine à chaîne latérale fluorée
|
JP2015512404A
(ja)
|
2012-03-26 |
2015-04-27 |
ユニバーシティー オブ アイオワ リサーチ ファウンデーション |
シュワインフルチン類似体
|
US9272016B2
(en)
|
2012-04-20 |
2016-03-01 |
University Of Iowa Research Foundation |
Methods to enhance RNAi oligonucleotide delivery to respiratory epithelial cells
|
US9717742B2
(en)
|
2012-05-07 |
2017-08-01 |
The Regents Of The University Of California |
Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis
|
EP2852390A1
(fr)
|
2012-05-21 |
2015-04-01 |
Chemi Nutra Inc. |
Compositions et procédés pour l'augmentation de la force et de la masse musculaire
|
WO2013177458A1
(fr)
|
2012-05-23 |
2013-11-28 |
Chemi Nutra |
Compositions destinées à augmenter la force, la masse musculaire et la masse corporelle maigre
|
EP2854834A4
(fr)
|
2012-05-30 |
2016-05-18 |
Biostrategies LC |
Lectines végétales utilisées en tant qu'excipient de substances médicamenteuses associées dans des cellules animales et humaines
|
WO2013188882A1
(fr)
|
2012-06-15 |
2013-12-19 |
Rutgers, The State University Of New Jersey |
Macromolécules pour le traitement de l'athérosclérose
|
US9175010B2
(en)
|
2012-06-18 |
2015-11-03 |
Dart Neuroscience (Cayman) Ltd. |
Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-ones
|
US9315495B2
(en)
|
2012-06-19 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: aryl myxopyronin derivatives
|
EP2863910B1
(fr)
|
2012-06-20 |
2020-03-11 |
University Of Virginia Patent Foundation |
Compositions et procédés pour réguler l'homéostasie du glucose et l'action de l'insuline
|
WO2014008407A1
(fr)
|
2012-07-05 |
2014-01-09 |
University Of Iowa Research Foundation |
Bisphosphonates thérapeutiques
|
CA2876021C
(fr)
|
2012-07-10 |
2020-09-22 |
Xpd Holdings, Llc |
Composes antioxydants multifonctionnels stabilises et procedes d'utilisation
|
RU2696278C2
(ru)
|
2012-07-18 |
2019-08-01 |
Юниверсити Оф Нотр Дам Дю Лак |
5,5-гетероароматические противоинфекционные соединения
|
WO2014018671A1
(fr)
|
2012-07-24 |
2014-01-30 |
Regents Of The University Of Minnesota |
Composés thérapeutiques pour le traitement du cancer
|
US8865772B2
(en)
|
2012-07-26 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating skin cancer
|
US10434082B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms
|
US9949943B2
(en)
|
2012-07-26 |
2018-04-24 |
The William M. Yarbrough Foundation |
Method for treating neurodegenerative diseases
|
US10335387B2
(en)
|
2012-07-26 |
2019-07-02 |
The William M. Yarbrough Foundation |
Method for treating infectious diseases with isothiocyanate functional compounds
|
US10434081B2
(en)
|
2012-07-26 |
2019-10-08 |
The William M. Yarbrough Foundation |
Inhibitors of macrophage migration inhibitory factor
|
US9839621B2
(en)
|
2012-07-26 |
2017-12-12 |
The William M. Yarbrough Foundation |
Method for treating bladder cancer
|
US10080734B2
(en)
|
2012-07-26 |
2018-09-25 |
The William M. Yarbrough Foundation |
Method for treating autism and other neurodevelopmental disorders
|
US10441561B2
(en)
|
2012-07-26 |
2019-10-15 |
The William M. Yanbrough Foundation |
Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer
|
MY171486A
(en)
|
2012-07-27 |
2019-10-15 |
Biogen Ma Inc |
Atx modulating agents
|
NZ703992A
(en)
|
2012-08-01 |
2018-04-27 |
Lewis And Clark Pharmaceuticals Inc |
N-alkyl 2-(disubstituted)alkynyladenosine-5’-uronamides as a2a agonists
|
AU2013296187B2
(en)
|
2012-08-03 |
2016-09-29 |
The Board Of Trustees Of The University Of Illinois |
Enzyme-activating compounds and compositions
|
ES2660287T3
(es)
|
2012-08-06 |
2018-03-21 |
Biogen Ma Inc. |
Compuestos que son agentes moduladores de s1p y/o agentes moduladores de atx
|
EP2879673B1
(fr)
|
2012-08-06 |
2018-07-25 |
Biogen MA Inc. |
Dérivés de la naphthaline substitué 1,5,6 en tant que modulateurs du récepteur sphingosine 1 phosphate (S1P) et/ou autotaxin (ATX) pour le traitement de maladies d'inflammation et d'auto-immunité
|
WO2014028025A1
(fr)
|
2012-08-16 |
2014-02-20 |
University Of Southern California |
Compositions et procédés pour le traitement de la dystrophie myotonique de type 1
|
DK2888010T3
(da)
|
2012-08-22 |
2021-06-28 |
Univ Cornell |
Fremgangsmåder til at hæmme fascin
|
US9737493B2
(en)
|
2012-09-07 |
2017-08-22 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for modulating DNMT1 inhibitor activity
|
WO2014043252A2
(fr)
|
2012-09-11 |
2014-03-20 |
Rutgers, The State University Of New Jersey |
Hydroxypyridones, hydroxypyrimidinones et hydroxypyridazinones thérapeutiques
|
WO2014041546A1
(fr)
|
2012-09-13 |
2014-03-20 |
Ben-Gurion University Of The Negev Research And Development Authority |
Agents de diagnostic à sensibilité/spécificité améliorées
|
WO2014043510A1
(fr)
|
2012-09-13 |
2014-03-20 |
Chang Gung Memorial Hospital |
Nouvelle composition pharmaceutique et ses utilisations
|
NZ705815A
(en)
|
2012-09-26 |
2018-08-31 |
Aragon Pharmaceuticals Inc |
Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
|
EP2906260B1
(fr)
|
2012-10-09 |
2019-06-26 |
Case Western Reserve University |
Nanoparticules de virus de plante en forme de bâtonnet en tant que plates-formes d'agent d'imagerie
|
US9957214B2
(en)
|
2012-10-10 |
2018-05-01 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Multifunctional radical quenchers
|
US20140120057A1
(en)
|
2012-10-25 |
2014-05-01 |
Rutgers, The State University Of New Jersey |
Polymers and methods thereof for wound healing
|
WO2014066840A1
(fr)
|
2012-10-26 |
2014-05-01 |
Regents Of The University Of Minnesota |
Inhibiteurs d'aurora kinase
|
WO2014070774A1
(fr)
|
2012-10-29 |
2014-05-08 |
Southern Methodist University |
Procédés de génération de composés de carbapénem résistants à la bêta-lactamase
|
BR112015010570B8
(pt)
|
2012-11-08 |
2021-04-20 |
Univ Rutgers |
agentes microbianos, composto e seu uso e composição farmacêutica
|
US9701638B2
(en)
|
2012-11-09 |
2017-07-11 |
Rutgers, The State University Of New Jersey |
Therapeutic hydroxyquinolones
|
MX2015005949A
(es)
|
2012-11-16 |
2015-09-08 |
Biocryst Pharm Inc |
Nucleosidos que contienen aza-azucar antiviral.
|
WO2014078857A1
(fr)
|
2012-11-19 |
2014-05-22 |
Regents Of The University Of Minnesota |
Dérivés d'ergoline en tant que modulateurs d'un récepteur de la dopamine
|
US9850206B2
(en)
|
2012-11-20 |
2017-12-26 |
Biogen Ma Inc. |
S1P and/or ATX modulating agents
|
EP2922821B1
(fr)
|
2012-11-20 |
2019-07-31 |
Biogen MA Inc. |
Agents de modulation de s1p et/ou atx
|
US9522131B2
(en)
|
2013-01-11 |
2016-12-20 |
Wisconsin Alumni Research Foundation |
Tannin-containing gastrointestinal formulations and methods of use
|
JOP20200097A1
(ar)
|
2013-01-15 |
2017-06-16 |
Aragon Pharmaceuticals Inc |
معدل مستقبل أندروجين واستخداماته
|
EP2951148A4
(fr)
|
2013-01-29 |
2016-09-21 |
Biogen Ma Inc |
Agents modulateurs de s1p
|
US9981043B2
(en)
|
2013-02-08 |
2018-05-29 |
Regents Of The University Of Minnesota |
Analgesic conjugates
|
KR20150119188A
(ko)
|
2013-02-15 |
2015-10-23 |
리젠츠 오브 더 유니버시티 오브 미네소타 |
입자 기능화
|
US9776975B2
(en)
|
2013-03-05 |
2017-10-03 |
University Of Notre Dame Du Lac |
Quinazolinone antibiotics
|
BR112015022202A2
(pt)
|
2013-03-14 |
2017-07-18 |
Dart Neuroscience Cayman Ltd |
compostos substituídos de naftiridina e quinolina como inibidores da mao
|
SG11201504709PA
(en)
|
2013-03-14 |
2015-07-30 |
Dart Neuroscience Llc |
Substituted pyridine and pyrazine compounds as pde4 inhibitors
|
WO2014152725A1
(fr)
|
2013-03-15 |
2014-09-25 |
Biogen Idec Ma Inc. |
Modulateurs de s1p et/ou de l'atx
|
WO2014143672A1
(fr)
|
2013-03-15 |
2014-09-18 |
Biogen Idec Ma Inc. |
Composés macrocycliques en tant qu'inhibiteurs de irak4 pour le traitement de maladies inflammatoires
|
MX368669B
(es)
|
2013-03-15 |
2019-10-10 |
Rexahn Pharmaceuticals Inc |
Procedimiento para la preparación de 4-amino-1-((1s,4r,5s)-2-fluor o-4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1h-pirimidin-2-o na.
|
MX2015012428A
(es)
|
2013-03-15 |
2016-01-12 |
Genentech Inc |
Tratamiento contra enfermedades mediadas th2 por inhibicion de bromodominios.
|
US9387250B2
(en)
|
2013-03-15 |
2016-07-12 |
Rutgers, The State University Of New Jersey |
Therapeutic compositions for bone repair
|
AU2014259672A1
(en)
|
2013-05-02 |
2015-12-03 |
The Regents Of The University Of California |
Bone-selective osteogenic oxysterol-bone targeting agents
|
WO2014182620A1
(fr)
|
2013-05-06 |
2014-11-13 |
Kaohsiung Chang Gung Memorial Hospital |
Composition pharmaceutique et utilisations de celle-ci
|
WO2014194055A1
(fr)
|
2013-05-29 |
2014-12-04 |
Rutgers, The State University Of New Jersey |
Poly(anhydride-esters) à base d'antioxydants
|
WO2014205194A1
(fr)
|
2013-06-22 |
2014-12-24 |
Nitor Therapeutics |
Compositions et méthodes de potentialisation de la réponse immunitaire pour le traitement des maladies infectieuses et du cancer
|
US10682415B2
(en)
|
2013-07-22 |
2020-06-16 |
Wisconsin Alumni Research Foundation |
Thermogel formulation for combination drug delivery
|
CA2920100A1
(fr)
|
2013-08-01 |
2015-02-05 |
Regents Of The University Of Minnesota |
Procede d'administration de medicament
|
CN104341504B
(zh)
|
2013-08-06 |
2017-10-24 |
百奥泰生物科技(广州)有限公司 |
双特异性抗体
|
EP3030241A4
(fr)
|
2013-08-06 |
2019-06-19 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs de la tyrosine kinase ack1/tnk2
|
WO2015038966A1
(fr)
|
2013-09-12 |
2015-03-19 |
Regents Of The University Of Minnesota |
Systèmes d'administration semi-solide
|
WO2015057863A1
(fr)
|
2013-10-15 |
2015-04-23 |
Regents Of The University Of Minnesota |
Réactifs triorthogonaux pour la conjugaison de protéines mixtes
|
CN112353791A
(zh)
|
2013-11-11 |
2021-02-12 |
夸利蒂赫布丘蒂克斯公司 |
卡瓦衍生的治疗性化合物及其使用方法
|
US9387199B2
(en)
|
2013-11-12 |
2016-07-12 |
University Of Virginia Patent Foundation |
Compositions and methods for treating clostridium infection and preventing recurrence of infection
|
US9339482B2
(en)
|
2013-11-22 |
2016-05-17 |
Regents Of The University Of Minnesota |
Methods to treat dysregulated blood glucose disorders
|
US9315523B2
(en)
|
2013-12-06 |
2016-04-19 |
Rutgers, The State University Of New Jersey |
Cyclic dinucleosides
|
WO2015109318A2
(fr)
|
2014-01-17 |
2015-07-23 |
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University |
Méthodes thérapeutiques
|
EP3102193B1
(fr)
|
2014-02-06 |
2023-01-11 |
Rutgers, The State University of New Jersey |
Agents antibactériens : n(alpha)-aroyl-n-aryl-phénylalaninamides
|
WO2015123654A1
(fr)
|
2014-02-17 |
2015-08-20 |
The Cleveland Clinic Foundation |
Nanoparticules amine-passivées pour le traitement et l'imagerie du cancer
|
DK3107902T3
(da)
|
2014-02-20 |
2021-05-03 |
Cornell Univ Cornell Center For Technology Enterprise & Commercialization Cctec |
Forbindelser og fremgangsmåder til at hæmme fascin
|
US10189874B2
(en)
|
2014-02-26 |
2019-01-29 |
Arizona Board Of Regents On Behalf Of Arizona State University |
DNA gridiron compositions and methods
|
WO2015130973A1
(fr)
|
2014-02-26 |
2015-09-03 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Composés thérapeutiques
|
US10272055B2
(en)
|
2014-03-06 |
2019-04-30 |
Regents Of The University Of Minnesota |
Therapeutic compounds and methods
|
AU2015226855C1
(en)
|
2014-03-07 |
2021-02-11 |
Biocryst Pharmaceuticals, Inc. |
Human plasma kallikrein inhibitors
|
US10197575B2
(en)
|
2014-03-31 |
2019-02-05 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
CA2946112C
(fr)
|
2014-04-18 |
2020-11-24 |
The Governors Of The University Of Alberta |
Therapie ciblee pour restaurer le transport de l'iode radioactif pour traiter le cancer de la thyroide
|
RU2659070C9
(ru)
|
2014-04-23 |
2018-08-24 |
Дарт Нейросайенс (Кайман) Лтд. |
ЗАМЕЩЕННЫЕ [1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИН-7-ИЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ PDE2
|
EP3134406A1
(fr)
|
2014-04-24 |
2017-03-01 |
Dart Neuroscience (Cayman) Ltd |
Composés de 2,4,5,6-tétrahydropyrrolo[3,4-c]pyrazole et 4,5,6,7-tétrahydro-2 h-pyrazolo [4,3-c]pyridine utilisés comme inhibiteurs de glyt1
|
US9556113B2
(en)
|
2014-04-29 |
2017-01-31 |
The South Dakota Board Of Regents |
Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment
|
US9987299B2
(en)
|
2014-05-05 |
2018-06-05 |
University Of Iowa Research Foundation |
Methods of improving RNAi in well-differentiated airway epithelia
|
EP3152206A1
(fr)
|
2014-06-06 |
2017-04-12 |
Biogen MA Inc. |
Agents de modulation d'atx
|
WO2015191742A1
(fr)
|
2014-06-13 |
2015-12-17 |
Rutgers, The State University Of New Jersey |
Procédé et intermédiaires pouvant être utilisés pour la préparation de polyanhydride-polyesters
|
US10138203B2
(en)
|
2014-06-16 |
2018-11-27 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
NL2013661B1
(en)
|
2014-10-21 |
2016-10-05 |
Ablynx Nv |
KV1.3 Binding immunoglobulins.
|
US9737598B2
(en)
|
2014-06-30 |
2017-08-22 |
Regents Of The University Of Minnesota |
CD200 inhibitors and methods of use thereof
|
EP3912635A1
(fr)
|
2014-07-11 |
2021-11-24 |
Biostrategies LC |
Matériaux et procédés pour traiter des troubles associés aux enzymes sulfatases
|
AR101229A1
(es)
|
2014-07-18 |
2016-11-30 |
Biogen Ma Inc |
Agentes inhibidores de irak4
|
SG11201700978SA
(en)
*
|
2014-08-19 |
2017-03-30 |
Univ Okayama Nat Univ Corp |
Method for enhancing immune cell function and method for assessing immune cell multifunctionality
|
AU2015304860B2
(en)
|
2014-08-19 |
2020-07-16 |
Hsiri Therapeutics, LLC |
Antibacterial sideromycins
|
WO2016037171A1
(fr)
|
2014-09-05 |
2016-03-10 |
The Cleveland Clinic Foundation |
Flavonoïdes inhibiteurs d'il-17a
|
US9630905B2
(en)
|
2014-09-08 |
2017-04-25 |
Rutgers, The State University Of New Jersey |
Amphiphilic macromolecules and methods of use thereof
|
US11135178B2
(en)
|
2014-09-11 |
2021-10-05 |
University Of Iowa Research Foundation |
Thymol and carvacol for use in medicine
|
US10328114B2
(en)
|
2014-10-28 |
2019-06-25 |
University Of Iowa Research Foundation |
Lung injury repair compositions and methods
|
US10239882B2
(en)
|
2014-11-05 |
2019-03-26 |
Dart Neuroscience (Cayman) Ltd. |
Substituted 5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine compounds as PDE2 inhibitors
|
TWI601712B
(zh)
|
2014-11-05 |
2017-10-11 |
達特神經科學(開曼)有限責任公司 |
作為glyt1抑制劑之經取代之氮雜環丁基化合物
|
CN115414480A
(zh)
*
|
2014-11-10 |
2022-12-02 |
德玛医药 |
结合放射用于治疗非小细胞肺癌和多形性胶质母细胞瘤的二去水卫矛醇
|
WO2016076929A1
(fr)
|
2014-11-13 |
2016-05-19 |
University Of Iowa Research Foundation |
Procédés pour générer des cellules épithéliales
|
MX2017006382A
(es)
|
2014-11-17 |
2018-04-10 |
Cellectar Biosciences Inc |
Analogos de eter fosfolipidico como portadores de farmacos dirigidos a cancer.
|
ES2772348T3
(es)
|
2014-12-19 |
2020-07-07 |
Ablynx Nv |
Dímeros de Nanobody con uniones cisteína
|
CN107405388A
(zh)
|
2015-01-08 |
2017-11-28 |
衣阿华大学研究基金会 |
用于体内关节软骨再生的方法
|
AU2016206491A1
(en)
|
2015-01-16 |
2017-08-31 |
University Of Iowa Research Foundation |
Methods to prevent or treat periodontitis or peri-implantitis
|
JP6770534B2
(ja)
|
2015-02-17 |
2020-10-21 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ |
治療用化合物
|
JP6807337B2
(ja)
|
2015-02-17 |
2021-01-06 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ |
ミトコンドリア治療剤としてのフェノチアジン類似体
|
US10112917B2
(en)
|
2015-03-03 |
2018-10-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
US10221143B2
(en)
|
2015-03-03 |
2019-03-05 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Substituted anilines for treatment of animal diseases
|
CN108112235A
(zh)
|
2015-03-06 |
2018-06-01 |
克利夫兰临床基金会 |
改变类固醇代谢以用于治疗类固醇依赖性疾病
|
US9926261B2
(en)
|
2015-03-10 |
2018-03-27 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
US9950993B2
(en)
|
2015-03-13 |
2018-04-24 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
JP6930918B6
(ja)
|
2015-04-10 |
2021-12-15 |
ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー |
コウジ酸ポリマー
|
EP3294316A4
(fr)
|
2015-05-06 |
2018-10-17 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Agents théarapeutiques et agents d'imagerie compagnons ciblant le mc1r
|
WO2016179587A1
(fr)
|
2015-05-07 |
2016-11-10 |
Kuality Herbceutics Llc |
Composés thérapeutiques et leurs méthodes utilisation
|
US20180125780A1
(en)
|
2015-05-15 |
2018-05-10 |
The Methodist Hospital System |
Implantable nanochannel delivery devices
|
WO2016187264A1
(fr)
|
2015-05-18 |
2016-11-24 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Amélioration de la prévention du cancer par de nouvelles mélanotrines
|
US10350207B2
(en)
|
2015-06-05 |
2019-07-16 |
The Board Of Trustees Of The University Of Illinois |
PAC-1 combination therapy
|
TW201710503A
(zh)
|
2015-06-12 |
2017-03-16 |
長庚醫療財團法人林口長庚紀念醫院 |
新穎多核苷酸、載體、醫藥組成物以及其用途
|
WO2016205397A2
(fr)
|
2015-06-15 |
2016-12-22 |
Klibanov Alexander L |
Administration spécifique de cible d'agents thérapeutiques
|
WO2016205534A1
(fr)
|
2015-06-16 |
2016-12-22 |
Lazo John S |
Inhibiteurs de ptp4a3 pour le traitement du cancer
|
US9399039B1
(en)
|
2015-06-30 |
2016-07-26 |
University Of South Florida |
Inhibitors of the FKBP51 protein from a high-throughput drug screen and methods of use
|
US10814006B2
(en)
|
2015-07-14 |
2020-10-27 |
University Of Iowa Research Foundation |
Fluorescent prodrugs
|
EP3725332B1
(fr)
|
2015-07-16 |
2023-10-04 |
Case Western Reserve University |
Particules de phytovirus pour l'administration d'agents antimitotiques
|
US10729669B2
(en)
|
2015-07-28 |
2020-08-04 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
US10336734B2
(en)
|
2015-08-02 |
2019-07-02 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibitors of ACK1/TNK2 tyrosine kinase
|
WO2017027883A1
(fr)
|
2015-08-13 |
2017-02-16 |
San Diego State University Research Foundation |
Atropisomérisme pour une sélectivité accrue des inhibiteurs de kinase
|
JP6639651B2
(ja)
|
2015-09-04 |
2020-02-05 |
ヤンセン ファーマシューティカ エヌ.ベー. |
疼痛のための治療化合物及びその合成
|
PL4019022T3
(pl)
|
2015-10-01 |
2024-06-24 |
Biocryst Pharmaceuticals, Inc. |
Inhibitory ludzkiej kalikreiny osoczowej
|
US10738016B2
(en)
|
2015-10-13 |
2020-08-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-kinase inhibitors as cancer therapeutics
|
US20180296531A1
(en)
|
2015-10-20 |
2018-10-18 |
The Cleveland Clinic Foundation |
Stimulation of 11b-hsd2 expression to improve hormonal therapy of steroid-dependent disease
|
EP4410376A2
(fr)
|
2015-11-03 |
2024-08-07 |
Regents of the University of Minnesota |
Inhibiteurs de cd200 et leurs procédés d'utilisation
|
CA3005730A1
(fr)
|
2015-11-20 |
2017-05-26 |
Senhwa Biosciences, Inc. |
Polytherapie comprenant des analogues de la quinolone tetracyclique pour le traitement du cancer
|
US9957282B2
(en)
|
2015-12-14 |
2018-05-01 |
Senhwa Biosciences, Inc. |
Crystalline forms of quinolone analogs and their salts
|
US9980951B2
(en)
|
2015-12-17 |
2018-05-29 |
University Of Iowa Research Foundation |
Image guided therapy for cancer
|
TWI726969B
(zh)
|
2016-01-11 |
2021-05-11 |
比利時商健生藥品公司 |
用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
|
WO2017127430A1
(fr)
|
2016-01-20 |
2017-07-27 |
Biogen Ma Inc. |
Agents inhibiteurs d'irak4
|
TWI747873B
(zh)
|
2016-02-01 |
2021-12-01 |
美商百歐克斯製藥公司 |
苯并吡唑化合物及其類似物
|
WO2017156527A1
(fr)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteurs des kinases aurora et des janus kinases pour la prévention de la maladie du greffon contre l'hôte
|
EP3429996A4
(fr)
|
2016-03-16 |
2020-02-12 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Petites molécules dirigées contre le céréblon pour améliorer la fonction des lymphocytes t effecteurs
|
US11529340B2
(en)
|
2016-03-22 |
2022-12-20 |
Regents Of The University Of Minnesota |
Combination for treating pain
|
US10759740B2
(en)
|
2016-03-24 |
2020-09-01 |
Rutgers, The State University Of New Jersey |
Antibacterial agents
|
JP2019515025A
(ja)
|
2016-04-04 |
2019-06-06 |
ラトガース ザ ステイト ユニバーシティー オブ ニュージャージー |
トポイソメラーゼ毒
|
US10551384B2
(en)
|
2016-04-07 |
2020-02-04 |
Rutgers, The State University Of New Jersey |
MTOR kinase mutations and methods of use thereof
|
DK3445838T3
(da)
|
2016-04-18 |
2023-05-30 |
Gene Pool Tech Inc |
Isolering af planteekstrakter
|
RU2018142711A
(ru)
|
2016-05-04 |
2020-06-04 |
Х. Ли Моффитт Кэнсер Сентер Энд Рисёч Инститьют, Инк. |
Средство для целенаправленного воздействия на дельта-опиоидный рецептор для молекулярной визуализации и иммунотерапии рака
|
US11697851B2
(en)
|
2016-05-24 |
2023-07-11 |
The Regents Of The University Of California |
Early ovarian cancer detection diagnostic test based on mRNA isoforms
|
CN115192719B
(zh)
|
2016-05-26 |
2024-03-01 |
匹兹堡大学联邦高等教育系统 |
用于治疗肺血管疾病的组合物和方法
|
US10899793B2
(en)
|
2016-05-27 |
2021-01-26 |
Regents Of The University Of Minnesota |
Melanocortin ligands and methods of use thereof
|
WO2017214296A1
(fr)
|
2016-06-07 |
2017-12-14 |
University Of Iowa Research Foundation |
Fragments de junctophiline-2 et leurs utilisations
|
MX2018015990A
(es)
|
2016-06-20 |
2019-10-07 |
Univ Rutgers |
Compuestos terapeuticos.
|
EP3474879A4
(fr)
|
2016-06-24 |
2020-05-06 |
University of Iowa Research Foundation |
Compositions et procédés de traitement d'un mélanome
|
EP3490552B1
(fr)
|
2016-07-26 |
2022-11-23 |
University of Southern California |
Inhibition sélective de bromodomaine de bdf1 fongique
|
US20180037909A1
(en)
|
2016-08-04 |
2018-02-08 |
Chang Gung Memorial Hospital, Linkou |
Modified cancer cell lines and uses thereof
|
US11390605B2
(en)
|
2016-08-25 |
2022-07-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
|
JP7033139B2
(ja)
|
2016-08-31 |
2022-03-09 |
ダート・ニューロサイエンス・エルエルシー |
障害の治療のためのヒドロキシノルケタミン誘導体
|
SG11201903348UA
(en)
|
2016-10-17 |
2019-05-30 |
Genentech Inc |
Therapeutic compounds and methods of use thereof
|
US11124541B2
(en)
|
2016-10-18 |
2021-09-21 |
Regents Of The University Of Minnesota |
Chimeric melanocortin ligands and methods of use thereof
|
MA46642A
(fr)
|
2016-10-31 |
2021-04-21 |
Biocryst Pharm Inc |
Promédicaments d'inhibiteurs de la kallicréine
|
US11071747B2
(en)
|
2016-11-29 |
2021-07-27 |
University Of Iowa Research Foundation |
Use of NAD precursors for breast enhancement
|
EP3554285A4
(fr)
|
2016-11-29 |
2021-01-20 |
University of Iowa Research Foundation |
Utilisation de précurseurs de nad pour améliorer la santé maternelle et/ou la santé de la descendance
|
US20180194824A1
(en)
|
2016-12-14 |
2018-07-12 |
University Of Iowa Research Foundation |
Musclin peptides and methods of use thereof
|
ES2970715T3
(es)
|
2016-12-22 |
2024-05-30 |
Prec Pharmaceuticals Inc |
Composiciones y métodos para inhibir la actividad de la arginasa
|
AR110590A1
(es)
|
2016-12-27 |
2019-04-10 |
Biogen Ma Inc |
Activador de nrf2
|
CA3047408A1
(fr)
|
2016-12-28 |
2018-07-05 |
Dart Neuroscience, Llc |
Composes pyrazolopyrimidinone substitues en tant qu'inhibiteurs de pde2
|
US10710957B2
(en)
|
2017-01-09 |
2020-07-14 |
University Of Central Florida Research Foundation, Inc. |
Motuporamine derivatives as antimicrobial agents and antibiotic enhancers against resistant gram-negative bacteria
|
US20180230105A1
(en)
|
2017-01-13 |
2018-08-16 |
Regents Of The University Of Minnesota |
Therapeutic compounds
|
WO2018136792A1
(fr)
|
2017-01-20 |
2018-07-26 |
The Regents Of The University Of California |
Inhibiteurs du domaine n-terminal du récepteur d'androgène
|
US10238655B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Dihydroindene and tetrahydronaphthalene compounds
|
US10231947B2
(en)
|
2017-01-23 |
2019-03-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Isochroman compounds and methods of use thereof
|
US10238626B2
(en)
|
2017-01-23 |
2019-03-26 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Therapeutic compounds
|
US11090289B2
(en)
|
2017-01-24 |
2021-08-17 |
University Of Virginia Patent Foundation |
Compositions and methods for blocking sodium channels
|
US20190389830A1
(en)
|
2017-01-30 |
2019-12-26 |
Biogen Ma Inc. |
Nrf2 activator
|
US20190389836A1
(en)
|
2017-01-30 |
2019-12-26 |
Biogen Ma Inc. |
Nrf2 activator
|
US11168095B2
(en)
|
2017-02-07 |
2021-11-09 |
Biogen Ma Inc. |
ASK1 inhibiting agents
|
US11260050B2
(en)
|
2017-02-16 |
2022-03-01 |
United States Government As Represented By The Department Of Veterans Affairs |
Combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological
|
US11938114B2
(en)
|
2017-03-10 |
2024-03-26 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
EP3592736A1
(fr)
|
2017-03-10 |
2020-01-15 |
Rutgers, the State University of New Jersey |
Dérivés d'indole utilisés en tant qu'inhibiteurs de pompe d'efflux
|
US11180459B2
(en)
|
2017-03-10 |
2021-11-23 |
Rutgers, The State University Of New Jersey |
Bacterial efflux pump inhibitors
|
JOP20190233A1
(ar)
|
2017-04-14 |
2019-10-02 |
Biogen Ma Inc |
نظائر بنزوازيبين بوصفها عوامل مثبطة لتيروزين كيناز بروتون
|
US10294264B2
(en)
|
2017-04-21 |
2019-05-21 |
Warsaw Orthopedic, Inc. |
Oxysterol-therapeutic agent derivative for bone healing
|
WO2018209355A1
(fr)
|
2017-05-12 |
2018-11-15 |
Innovus Pharmaceuticals, Inc. |
Méthodes thérapeutiques et compositions associees
|
US10434106B2
(en)
|
2017-05-19 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Oxysterol-statin compounds for bone growth
|
EP3630115A1
(fr)
|
2017-05-22 |
2020-04-08 |
University Of Virginia Patent Foundation |
Compositions et méthodes de préparation et d'utilisation de découpleurs mitochondriaux
|
JP7281822B2
(ja)
|
2017-05-26 |
2023-05-26 |
ラトガーズ、ザ ステイト ユニバーシティ オブ ニュージャージー |
細菌の排出ポンプ阻害剤
|
TW202413408A
(zh)
|
2017-06-02 |
2024-04-01 |
比利時商艾伯林克斯公司 |
結合聚集蛋白聚糖之免疫球蛋白
|
JP2020521804A
(ja)
|
2017-06-02 |
2020-07-27 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
Mmp13結合免疫グロブリン
|
CN111032695B
(zh)
|
2017-06-02 |
2024-06-25 |
默克专利股份有限公司 |
结合adamts的免疫球蛋白
|
MX2019014397A
(es)
|
2017-06-02 |
2020-02-10 |
Merck Patent Gmbh |
Polipeptidos que enlazan adamts5, mmp13 y agrecano.
|
AR112027A1
(es)
|
2017-06-15 |
2019-09-11 |
Biocryst Pharm Inc |
Inhibidores de alk 2 quinasa que contienen imidazol
|
WO2018237241A1
(fr)
|
2017-06-22 |
2018-12-27 |
University Of Virginia Patent Foundation |
Médecine atomique activée par protons
|
EP3641776B1
(fr)
|
2017-06-23 |
2023-10-18 |
San Diego State University Research Foundation |
Atropisomérisme pour une sélectivité améliorée des inhibiteurs de kinase
|
WO2019005841A1
(fr)
|
2017-06-26 |
2019-01-03 |
Rutgers, The State University Of New Jersey |
Composés thérapeutiques et méthodes pour traiter une infection
|
JP7213863B2
(ja)
|
2017-07-12 |
2023-01-27 |
ダート・ニューロサイエンス・エルエルシー |
Pde7阻害剤としての置換ベンゾオキサゾール及びベンゾフラン化合物
|
CN107446050A
(zh)
|
2017-08-11 |
2017-12-08 |
百奥泰生物科技(广州)有限公司 |
Trop2阳性疾病治疗的化合物及方法
|
CN111479805B
(zh)
|
2017-08-29 |
2024-08-13 |
罗格斯新泽西州立大学 |
治疗性吲唑
|
EP3676380B1
(fr)
|
2017-08-30 |
2022-05-18 |
Arizona Board of Regents on behalf of Arizona State University |
Nanostructures arn et méthodes de fabrication et d'utilisation de nanostructures arn
|
AU2018345909A1
(en)
|
2017-10-06 |
2020-04-09 |
Blue Therapeutics, Inc. |
Methods of treating acute or chronic pain
|
JOP20200076A1
(ar)
|
2017-10-16 |
2020-04-30 |
Aragon Pharmaceuticals Inc |
مضادات أندروجين لعلاج سرطان البروستاتا غير النقيلي المقاوم للاستئصال
|
CA3116829A1
(fr)
|
2017-10-17 |
2019-04-25 |
The Methodist Hospital System |
Dispositifs d'administration
|
KR20200090771A
(ko)
|
2017-11-17 |
2020-07-29 |
더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 |
이중 mek 신호 전달 분해를 통한 암 치료
|
JP2021503481A
(ja)
|
2017-11-17 |
2021-02-12 |
サイトジェル ファーマ リミテッド ライアビリティ カンパニー |
μオピオイド受容体のポリマーアゴニスト
|
WO2019104030A1
(fr)
|
2017-11-21 |
2019-05-31 |
Biogen Ma Inc. |
Dérivés de tétrahydronaphtalène utiles en tant qu'activateurs de nrf2
|
CN111655695A
(zh)
|
2017-11-27 |
2020-09-11 |
达特神经科学有限公司 |
作为pde1抑制剂的取代的呋喃并嘧啶化合物
|
EP3716956B1
(fr)
|
2017-11-29 |
2024-06-26 |
The Cleveland Clinic Foundation |
Composés modulant tet2 antitumoraux
|
EP3716948B1
(fr)
|
2017-11-30 |
2023-11-22 |
Cytogel Pharma, LLC |
Nouvelles formulations pharmaceutiques analgésiques et leurs utilisations
|
WO2019112885A1
(fr)
|
2017-12-07 |
2019-06-13 |
The Cleveland Clinic Foundation |
Traitement d'une maladie résistant aux stéroïdes à l'aide d'une anthocyanine et d'un corticostéroïde
|
WO2019140140A1
(fr)
|
2018-01-10 |
2019-07-18 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Robots doubles nanostructurés par de l'arn et leurs méthodes d'utilisation
|
US10738093B2
(en)
|
2018-01-25 |
2020-08-11 |
The Hong Kong University Of Science And Technology |
Discovery of cationic nonribosomal peptides as Gram-negative antibiotics through global genome mining
|
US11685723B2
(en)
|
2018-02-13 |
2023-06-27 |
Rutgers, The State University Of New Jersey |
Antibacterial agents: O-alkyl-deuterated pyronins
|
CA3088998A1
(fr)
|
2018-02-15 |
2019-09-06 |
Senhwa Biosciences, Inc. |
Analogues de quinolone, sels correspondants, compositions et procede d'utilisation
|
WO2019168921A1
(fr)
|
2018-02-27 |
2019-09-06 |
University Of Virginia Patent Foundation |
Inhibiteur de liposomes/parp ciblés par plectine dans le traitement du cancer
|
AU2019229188B2
(en)
|
2018-02-28 |
2023-06-29 |
Dart Neuroscience, Llc |
Substituted cyclohexyl compounds as NOP inhibitors
|
WO2019173507A1
(fr)
|
2018-03-06 |
2019-09-12 |
Rutgers, The State University Of New Jersey |
Agents antibactériens : phloroglucinols arylalkylcarboxamido
|
WO2019178267A2
(fr)
|
2018-03-13 |
2019-09-19 |
University Of Iowa Research Foundation |
Régénération inductive des voies respiratoires par modulation du facteur transcriptionnel de cellules souches myoépithéliales glandulaires
|
JP7453916B2
(ja)
|
2018-03-14 |
2024-03-21 |
バイオジェン・エムエイ・インコーポレイテッド |
O-糖タンパク質-2-アセトアミド-2-デオキシ-3-d-グリコピラノシダーゼ阻害剤
|
TW202010742A
(zh)
|
2018-04-06 |
2020-03-16 |
美商百歐克斯製藥公司 |
取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑
|
AU2019256722A1
(en)
|
2018-04-20 |
2020-11-05 |
Virginia Tech Intellectual Properties, Inc. |
Imidazopyridines useful as mitochondrial uncouplers
|
WO2020036654A2
(fr)
|
2018-04-27 |
2020-02-20 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Topologies moléculaires hautement nouées à partir d'acides nucléiques monocaténaires
|
ES2968222T3
(es)
|
2018-05-14 |
2024-05-08 |
Biogen Ma Inc |
Agentes inhibidores para la tirosina cinasa de Bruton
|
TW202035389A
(zh)
|
2018-06-27 |
2020-10-01 |
美商百健Ma公司 |
Ask1抑制劑
|
CN112469420A
(zh)
|
2018-07-09 |
2021-03-09 |
台湾微脂体股份有限公司 |
减少关节内类固醇的并发症的方法
|
KR20210032430A
(ko)
|
2018-07-11 |
2021-03-24 |
에이치 리 모피트 캔서 센터 앤드 리서어치 인스티튜트 아이엔씨 |
세레블론-기반 메커니즘에 대한 이량체 면역-조절 화합물
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
WO2020028814A1
(fr)
|
2018-08-03 |
2020-02-06 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Inhibiteur allostérique de la kinase wee1
|
US11897898B2
(en)
|
2018-08-14 |
2024-02-13 |
Biogen Ma Inc. |
Pyridine macrocycle compounds as ASK1 inhibiting agents
|
BR112021002690A2
(pt)
|
2018-08-14 |
2021-05-11 |
Biogen Ma Inc. |
agentes inibidores de ask1
|
US11332499B2
(en)
|
2018-08-16 |
2022-05-17 |
Regents Of The University Of Minnesota |
Cyclic peptides and methods of use thereof
|
CN113056474A
(zh)
|
2018-09-13 |
2021-06-29 |
米尼阿姆里塔治疗学有限责任公司 |
用于治疗纤维化、nash和nafld的方法中的雷公藤内酯及其前药
|
BR112021004739A2
(pt)
|
2018-09-19 |
2021-06-01 |
Biogen Ma Inc. |
inibidores de o-glicoproteína-2-acetamido-2-desoxi-3-d-glucopiranosidase
|
WO2020081514A1
(fr)
|
2018-10-15 |
2020-04-23 |
Biogen Ma Inc. |
Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton
|
CN112996531A
(zh)
|
2018-10-17 |
2021-06-18 |
逊斯泰特生物科学有限责任公司 |
用于增强治疗效果的单一蛋白质包封的药剂
|
EP3877439A4
(fr)
|
2018-11-07 |
2022-08-10 |
Regents of the University of Minnesota |
Compositions analgésiques et anti-accoutumance pour le traitement de la douleur chronique et de la dépendance aux opioïdes
|
WO2020097433A1
(fr)
|
2018-11-09 |
2020-05-14 |
The University Of Rochester |
Méthodes et systèmes de traitement de cancer sur la base d'une prédiction de réponse à l'aide d'une technologie de diffusion de lumière
|
JP2022513114A
(ja)
|
2018-11-26 |
2022-02-07 |
デナリ セラピューティクス インコーポレイテッド |
脂質代謝調節不全の治療方法
|
WO2020117961A1
(fr)
|
2018-12-05 |
2020-06-11 |
Biogen Ma Inc. |
Inhibiteurs de morpholinyle, de pipérazinyle, d'oxazépanyle et de diazépanyle o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase
|
CA3126156A1
(fr)
|
2019-01-14 |
2020-07-23 |
Regents Of The University Of Minnesota |
Ligands cd200ar pour immunotherapie anticancereuse
|
US20220106305A1
(en)
|
2019-02-04 |
2022-04-07 |
Biogen Ma Inc. |
Bicyclic ether o-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors
|
EP3935055A1
(fr)
|
2019-03-08 |
2022-01-12 |
Biogen MA Inc. |
Inhibiteurs d'azétidinyl 0-glyc0pr0téin-2-acétamid0-2-désoxy-3-d-gluc0pyran0sidase
|
WO2020225779A1
(fr)
|
2019-05-09 |
2020-11-12 |
Istituto Pasteur Italia - Fondazione Cenci Bolognetti |
Agonistes de rig-i pour le traitement du cancer et l'immunothérapie
|
EP3969124A1
(fr)
|
2019-05-15 |
2022-03-23 |
Biogen MA Inc. |
Agents inhibiteurs de la tyrosine kinase de bruton
|
US20220241214A1
(en)
|
2019-06-20 |
2022-08-04 |
University Of Iowa Research Foundation |
Nanoparticles comprising quinone w methides and compositions for use
|
WO2020263989A1
(fr)
|
2019-06-24 |
2020-12-30 |
University Of Iowa Research Foundation |
Inhibiteurs de jnk en tant qu'agents anticancéreux
|
CR20220092A
(es)
|
2019-08-06 |
2022-06-03 |
Biocryst Pharm Inc |
Síntesis de un inhibidor de calicreína plasmática a escala de proceso
|
BR112022006739B1
(pt)
|
2019-10-10 |
2024-01-23 |
Cellectar Biosciences, Inc |
Conjugados fosfolipídio-flavagina e métodos de uso do mesmo para terapia direcionada a câncer
|
AU2020370281A1
(en)
|
2019-10-25 |
2022-05-26 |
Accent Therapeutics, Inc. |
METTL3 modulators
|
JP2023501949A
(ja)
|
2019-10-29 |
2023-01-20 |
バイオジェン・エムエイ・インコーポレイテッド |
スピロ環o-糖タンパク質-2-アセトアミド-2-デオキシ-3-d-グルコピラノシダーゼ阻害剤
|
WO2021087112A1
(fr)
|
2019-10-30 |
2021-05-06 |
Biogen Ma Inc. |
Bi-hétérocycles condensés utilisés en tant qu'agents inhibiteurs de la tyrosine kinase de bruton
|
EP4051679A1
(fr)
|
2019-10-30 |
2022-09-07 |
Biogen MA Inc. |
Pyridazine ou pyrimidine condensée utilisée en tant qu'inhibiteurs de btk
|
EP4081514A1
(fr)
|
2019-12-23 |
2022-11-02 |
Biogen MA Inc. |
Inhibiteurs de la btk
|
US20230053688A1
(en)
|
2020-01-10 |
2023-02-23 |
Cornell University |
Methods to alter latency in ebv+ malignancies
|
CA3183957A1
(fr)
|
2020-05-18 |
2021-11-25 |
Salk Institute For Biological Studies |
Derives de chromen-4-one, tels que par exemple des flavones, destines a etre utilises en tant qu'inhibiteurs de ck2 pour le traitement de la neuro-inflammation
|
CN116056693A
(zh)
|
2020-07-10 |
2023-05-02 |
长庚医疗财团法人林口长庚纪念医院 |
β-1肾上腺素受体拮抗剂用于制备减少表皮生长因子受体抑制剂诱导的上皮细胞损伤以及抑制癌细胞的组合物的用途
|
US11529335B2
(en)
|
2020-07-31 |
2022-12-20 |
University Of Iowa Research Foundation |
Compositions and methods for treating cancer
|
TW202220972A
(zh)
|
2020-08-07 |
2022-06-01 |
美商百健Ma公司 |
Btk抑制劑
|
CA3193736A1
(fr)
|
2020-09-02 |
2022-03-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Agents de degradation ciblant lzk et procedes d'utilisation
|
JP2023546549A
(ja)
|
2020-10-14 |
2023-11-02 |
アクセント・セラピューティクス・インコーポレイテッド |
Mettl3モジュレーター
|
WO2022150446A1
(fr)
|
2021-01-07 |
2022-07-14 |
Biogen Ma Inc. |
Inhibiteurs de tyk2
|
JP2024508426A
(ja)
|
2021-02-22 |
2024-02-27 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
免疫調節物質及び免疫調節物質コンジュゲート
|
TWI796023B
(zh)
|
2021-03-10 |
2023-03-11 |
長庚醫療財團法人 |
藥物組合物及其用途
|
WO2022212893A1
(fr)
|
2021-04-02 |
2022-10-06 |
Biogen Ma Inc. |
Méthodes de traitement combiné de la sclérose en plaques
|
KR20240004737A
(ko)
|
2021-05-04 |
2024-01-11 |
리젠츠 오브 더 유니버시티 오브 미네소타 |
피임 화합물 및 방법
|
US20240287076A1
(en)
|
2021-05-05 |
2024-08-29 |
Biogen Ma Inc. |
Compounds for targeting degradation of bruton's tyrosine kinase
|
JP2024523558A
(ja)
|
2021-06-22 |
2024-06-28 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
脳腫瘍の治療における使用のためのegfrの(1h-ピロロ[2,3-b]ピリジン-1-イル)ピリミジン-2-イル-アミノ-フェニル-アクリルアミド阻害剤
|
WO2022271951A1
(fr)
|
2021-06-23 |
2022-12-29 |
University Of Iowa Research Foundation |
Formulations à libération prolongée comprenant un modulateur sélectif du récepteur des androgènes
|
EP4366834A1
(fr)
|
2021-07-07 |
2024-05-15 |
Biogen MA Inc. |
Composés pour le ciblage de la dégradation de protéines irak4
|
EP4367113A1
(fr)
|
2021-07-07 |
2024-05-15 |
Biogen MA Inc. |
Composés pour le ciblage de la dégradation de protéines irak4
|
WO2023034808A1
(fr)
|
2021-09-01 |
2023-03-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibiteurs de kinase de lignée mixte et procédés d'utilisation
|
WO2023081237A1
(fr)
|
2021-11-03 |
2023-05-11 |
Regents Of The University Of Minnesota |
Agonistes et antagonistes du récepteur de type toll et leurs utilisations
|
WO2023086521A1
(fr)
|
2021-11-10 |
2023-05-19 |
Biogen Ma Inc. |
Inhibiteurs de btk
|
WO2023086575A1
(fr)
|
2021-11-12 |
2023-05-19 |
Biogen Ma Inc. |
Inhibiteurs de btk
|
US20240200078A1
(en)
|
2021-11-18 |
2024-06-20 |
Cornell University |
Microrna-dependent mrna switches for tissue-specific mrna-based therapies
|
WO2023130022A2
(fr)
|
2021-12-29 |
2023-07-06 |
University Of Iowa Research Foundation |
Compositions d'arn de cystatine pour l'ingénierie tissulaire
|
WO2023220046A1
(fr)
|
2022-05-10 |
2023-11-16 |
Biogen Ma Inc. |
Inhibiteurs de tyk2
|
WO2023220049A1
(fr)
|
2022-05-10 |
2023-11-16 |
Biogen Ma Inc. |
Polymorphes cristallins de n-méthyl-n-((1s,3s)-3-méthyl-3-((6-(1-méthyl-1h-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)oxy)cyclobutyl)acrylamide
|
WO2024006977A1
(fr)
|
2022-07-01 |
2024-01-04 |
University Of Southern California |
Ligands bitopiques du récepteur opioïde delta analgésique
|
WO2024006493A1
(fr)
|
2022-07-01 |
2024-01-04 |
Biogen Ma Inc. |
Inhibiteurs de tyk2
|
WO2024009283A1
(fr)
|
2022-07-07 |
2024-01-11 |
University Of Southern California |
Antagonistes at2 pour soulager la douleur non addictive
|
WO2024011214A1
(fr)
|
2022-07-08 |
2024-01-11 |
Actio Biosciences, Inc. |
Composés et méthodes thérapeutiques
|
WO2024100093A1
(fr)
|
2022-11-09 |
2024-05-16 |
Merck Patent Gmbh |
Agonistes du récepteur 7 de type toll utilisés en tant que stimulateurs immunitaires pour déclencher l'immunité antitumorale innée
|
WO2024112932A1
(fr)
|
2022-11-23 |
2024-05-30 |
Regents Of The University Of Minnesota |
Immunomodulateurs et conjugués immunomodulateurs
|
WO2024124023A2
(fr)
|
2022-12-07 |
2024-06-13 |
Rutgers, The State University Of New Jersey |
Inhibiteurs d'enzyme anhydrase carbonique et leurs procédés d'utilisation
|